UPDATE 21. August 2020: Curing a Virus like SARS-CoV-2 with Hydrogen Peroxide
UPDATE 28. July 2020: FOR MOST HYDROXICHLOROQUIN WORKS !!! (- if you don't suffer from Favism and it is not overdosed like in the Oxford trial, whose murders must be investigated.) Prevention: One 100mg tablet Hydroxychloroquine (HCQ) every three weeks (HCQ has haf-life of 21 days in the human body) plus daily Zinc intake. Cure of COVID-19: One 200mg tablet per day for 3 days. The 'Studies' (Oxford or Brazil) where doses of 800-1000mg HCQ per day were administered for 8 days, killed the patients - a clear medical malpractice. (Source: Immunologist and Virologist Prof. Dr. Dolores Cahill as well as the U.S. Frontline Doctors)
UPDATE 18. July 2020: COVID-19 - How can I cure thee? Let me count the ways.
UPDATE 10. July 2020: Top 6 Research-Backed Benefits Of Cistus Tea
UPDATE 15. February 2020: TOP ADVISE: IVERMECTIN
UPDATE 13. February 2020 - 16h00 UTC: ARTIFICIAL COVID-19 UPSURGE - It appears that the positive news of yesterday were contrary to what the Orwellian gamers have in mind. So they changed now the goalposts and the reporting system with a suddenly added report from Hubei / China with 14,840 new cases and 242 new deaths. Hubei Province will from now on include the number of just clinically diagnosed cases into the number of confirmed cases. Have they run out of test kits? Thereby COVID-19 now allegedly claimed 1,370 deaths - except 2 still all deaths in China - with 60,414 confirmed total infection cases, of which 59,823 occurred in China and 589 in 27 other countries. By now 7,665 cases are closed (6,295 recovered) and 52,749 cases are active. To provide for today the Daily Death Growth Factor and the Daily Cases Growth Factor, which we still believe are both below 1.0 in real terms, has become obsolete due to the changed system input. Since it was officially stated that also Hubei Province is now reporting their cases in conformity with other provinces, it becomes clear that also the other provinces already earlier just lumped clinically diagnosed cases together with confirmed cases - means any flu-like case became and becomes now officially a COVID-19 case in China - even if it is not confirmed. So, we better forget about China and the WHO concerning serious statistics. The political fallout from the outbreak escalated on Thursday with the firing of Hubei’s party chief, the party chief of Wuhan and the head of China’s Hong Kong and Macau affairs office. Ying Yong, the new party chief for Hubei, came up through the ranks in Zhejiang – where President Xi Jinping, previously served as party secretary – and was also part of anti-corruption campaigns, the Chinese president’s signature initiative.
UPDATE 12. February 2020: Finally the baby, whoever its procreator is, as a definite name: COVID-19 it is - or in full: Coronavirus Disease 2019. Ethiopian WHO chief Tedros Adhanom Ghebreyesus, whose nomination to the post had been opposed even by the vast majority of Ethiopians, who hail from the opposition Oromo people, revealed the final choice to reporters during a million-dollar gathering of "experts" in Geneva, who had to come up with a title for the virus. So far COVID-19 claimed 1,118 deaths - except 2 all deaths in China - with 45,211 confirmed total infection cases, of which 44,688 occurred in China and 523 in 27 other countries. By now 5,989 cases are closed (4,871 recovered) and 39,222 cases are active. A positive sign is that for the first time the Daily Death Growth Factor is with 0.98 below 1 and also the Daily Cases Growth Factor is further declining and stands today at 0.81. Are they already breeding COVID-20 ?
UPDATE 11. February 2020: So far 1,018 deaths - except 2 all deaths in China - are caused by 2019-nCoV, with 43,104 confirmed total infection cases, of which 42,667 are recorded in China and 437 in 27 other countries. By now 5,354 cases are closed (4,336 recovered) and 37,789 cases are active - reportedly with again declining case growth-factor - down from 1.12 to 0.85. Protective gear (facemasks and diagnostic tests) in short supply worldwide. China has launched a Coronavirus-App utilizing all their governmental surveillance databases combined to tell people, if they could be infected - BigBrother-games are in full swing. According to the WHO a vaccine could be available only in about 18 months. Scaremongers speculate with up to 1% of the global population being killed due to the virus infection. + Coronavirus 'could infect 60% of global population if unchecked'
ICYMI: 'An Orgasm a Day Keeps the Doctor Away!' - Orgasm boosts your immune system, helping you fight off infection and illness + New disease is greater threat than ebola and could overwhelm NHS
PROLOGUE: The coronavirus, that is creating worldwide havoc at present, was initially called 2019-nCoV for '2019 novel coronavirus' and is identified now as SARS-CoV-2. while the disease is called COVID-19 for 'Corona Virus Infectious Disease 2019'. Get your case updates from HERE or HERE or HERE or HERE or from this MAP. (base article was first published on 10. February 2020)
Vaccine-Induced Side Effects Due To Fill Hospitals In China Instead of Coronavirus Infections
By Bill Sardi - 10. February 2020
While laboratories around the world are racing to develop a safe and effective vaccine against the mutated coronavirus, now known as 2019-nCoV, which is said to have killed hundreds, and with rumors Chinese health authorities are hiding more dead bodies underneath the floor boards of their newly constructed coronavirus hospitals, there is already a non-vaccine cure.
(Because bots read these reports and censor them or bury them on obscure web pages when they refer to natural remedies, you need to use the direct link (click here) for the identity of the cure. Otherwise an online search would have been unlikely to find this report.)
Convincing visual lab-dish evidence is shown below.
CEPI: part of the problem or the solution?
Certainly, don’t tell a new world order organization called the Coalition for Epidemic Preparedness Innovations (CEPI) about this coronavirus cure.
CEPI is handing out research grants to develop a vaccine. This is free money to pharmaceutical and biotech companies and actually the whole reason for the conjured up epidemic, to develop a vaccine with public money.
CEPI is a private/public coalition headquartered in Norway with $760-billion of funding by various countries, the Wellcome Trust and the Bill & Melinda Gates Foundation.
Recognize the billion-dollar reward a pharma/biotech company could gain from approval of such a vaccine.
Why, it would make a pre-planned “killing” in the stock market, as three such companies have been awarded research grants by CEPI.
CEPI: Not just a funding agency
CEPI is not just a funding agency.
As Science Magazine report says: “CEPI supports began within hours after Chinese researchers first posted a sequence of 2019-nCoV/R in a public database. That happened on Friday evening, 10 January, in Bethesda, Maryland, home of the U.S. National Institute of Allergy and Infectious Diseases (NIAID).”
CEPI researchers began to analyze the sequence of genes within the virus the next morning.
Overkill by the World Health Organization
What has part of the world on lockdown is the news-media-generated fear of this rarely mortal, slow-to-spread virus. In an overkill by the World Health Organization, when air travelers return home from a trip to China they are placed in quarantine for two weeks.
The current fear being spread over the 2019-nCoR viral epidemic appears to be a drill to test public health quarantine measures. As onerous as these quarantines are, it appears these extreme measures have been no more effective in preventing deaths in 2019-2020 compared to the SARS epidemic of 2003.
As of February 8, 34,958 cases of coronavirus have been confirmed and 724 deaths worldwide (2% died). According to the Centers for Disease Control, the 2003 SARS outbreak reportedly infected 8,098 people and resulted in 774 deaths (9.6% died).
Rate of infection limits effectiveness of any future vaccine
As of February 7 there were 24,953 cases in Wuhan and its environs, a city of 11 million.
Presuming all cases of coronavirus in greater Wuhan have been reported to health authorities, the risk for infection would only be 6 in 100,000, a very remote risk. The risk for death is even more improbable.
Yet everyone will be expected to be inoculated once a vaccine is developed, approved and available.
In other words, if a vaccine were developed for this 2019-nCor coronavirus, 16,666 people would need to be vaccinated to prevent 1 case of coronavirus infection. So, off the top, given the high number of people needed to vaccinate to prevent just one case of viral illness, vaccines would be categorically ineffective and costly.
If a vaccine were developed for this 2019-nCor coronavirus, 16,666 people would need to be vaccinated
to prevent 1 case of coronavirus infection.
How many would avert coronavirus infection versus side effects?
Let’s assume that all coronavirus infections have been reported to health authorities in Wuhan, China.
Let’s assume the occurrence of severe side effects from any upcoming approved 2019-nCoR coronavirus vaccine were the same as flu shots.
Let’s presume 15% of Wuhan’s population is over age 65 and a vaccination rate of 100%.
That would amount to 1,650,000 vaccinated elderly individuals.
Let’s use a study of senior adults in the U.S. (a well-fed population) that received standard and high-dose inactivated trivalent (three strains) flu vaccine for comparison, where severe side effects were reported for 0.6% and 1.3% of vaccinated subjects respectively.
Given that the infection rate in a population such as Wuhan is just 1 in 16,666 without vaccination in the population overall, and a higher anticipated rate of infection would be expected among senior adults, let’s say 30%, which would amount to 4,999 infected among every 16,666 elderly Wuhan residents. That would amount to 495,000 coronavirus infections among an estimated 1,650,000 elderly unvaccinated residents of Wuhan.
Let’s presume any newly approved coronavirus vaccine is only 50% effective at reducing coronavirus infections rates among elderly Wuhan residents based upon recent data for vaccine effectiveness studies for flu vaccine. So maybe 247,500 cases would be prevented out of an estimated population of infected and uninfected population of 1,650,000.
If the current death rate from coronavirus of 2% among infected individuals is factored, then an estimated 4950 lives out of 247,500 infected patients would be spared due to vaccination.
Using the data from a U.S. population of similar age (cited above), severe side effects would be expected to occur in 216-1000 of every 16,666 vaccinated senior adults.
Therefore, an estimated 21,384-99,000 out of 1,650,000 vaccinated senior adults in Wuhan would be expected to experience severe side effects from the vaccine leading to hospitalization. How many vaccine-related and treatment-related deaths would occur is unknown. Severe side effects and possibly vaccine/treatment-related deaths would vastly outnumber the number of lives saved via vaccination.
Those widely publicized instant-built hospitals in Wuhan for the coronavirus would largely be filled with patients suffering severe vaccine-related side effects, not the coronavirus infection itself.
My comparisons herein are more than fair to an imagined coronavirus vaccine because I’m comparing vaccine effectiveness and side effect data from healthy elderly U.S. populations versus actual data from the current coronavirus in a presumably less healthy older population suffering from a coronavirus epidemic now underway in Wuhan, China.
Once mass vaccination would be forced upon the population in China, hospitals would fill with patients experiencing severe vaccine-induced side effects and would be easily confused with cases of severe coronavirus infection, leading to needless public panic, fear and needless death from treatment-related causes.
Latrogenic (treatment-induced) deaths would further worsen outcomes.
- Allergic reaction
- Anaphylactic shock
- Bell’s palsy
- Brachial plexus neuropathy
- Brain damage
- Cranial nerve paralysis
- Erythema multiforme
- Extensive limb swelling
- Febrile seizures
- Flu-like illness
- Guillain-Barré Syndrome
- Microscopic polyangitis
- Migraine headache
- Nerve damage (neuropathy)
- Neurological disorders
- Numbness and tingling
- Optic neuritis
- Partial facial paralysis
- Respiratory distress
- Serum sickness
- SIRVA (Shoulder Injury Related to Vaccine Administration)
- Skin reactions
- Spinal cord inflammation
- Stevens-Johnson Syndrome
- Syncope and pre-syncope (fainting)
- Tonic-clonic limb movements
- Transverse myelitis
- Upper respiratory tract infection
- Vasculitis with transient kidney involvement
- Vision problems
Note: It is difficult to locate a list of severe side effects caused by flu vaccination.
There is online censoring of information about serious side effects of vaccines. An online search conducted for “severe side effects, flu vaccine” redirects and never leads to a source that lists severe side effects.
Try such search for yourself.
CEPI: focus on immune compromised individuals
Given that coronavirus vaccine would likely be in limited supply a CEPI representative says: “It appears at this point in time that older individuals, probably immune-compromised individuals, individuals with other medical conditions seem to be the ones who are affected the most by the severe disease… Each country needs to prioritize whatever vaccine becomes available for those who are identified as being at the highest risk.”
Finally, an admission that there are only a small number of people who are at high-risk to develop coronaviral infections and, by the way, they happen to be the least likely to successfully develop antibodies to any virus following vaccination.
Why would the elderly be most vulnerable to coronavirus?
Answer: Because they don’t develop adequate antibodies.
So, the moronic response is either to develop a vaccine that contains an attenuated version of the virus itself and hope and pray it works in an immune compromised elderly adult population, or maybe even inject antibodies directly into at-risk individuals.
A report published in the Proceedings of the National Academy of Sciences notes the development of an antibody that binds to a coronavirus that would serve as prophylaxis against infection.
(Need coronavirus antibodies? You can purchase coronavirus antibodies online -$358 for a quarter of a milligram. But you just have to be a certified research lab to order.)
One plan is to develop antibodies that bind to viral proteins and, in doing so, stop the pathogen from readily infecting human cells.
Some scientific excitement surrounds the development of compound CR3022 which is said to bind and combine with antibodies that attack coronaviruses.
But why the search for antibodies against coronavirus when your body already has an organ dedicated to making them—the thymus gland (located under your breast plate)?
Broad-spectrum antivirals needed
With potentially seven strains of coronavirus in play, researchers are searching for a broad-spectrum remedy.
So just how can a vaccine be made that specifically protects against a strain of coronavirus when the virus itself is mutating mid-season?
Zinc-based remedies ignored
Of interest, in the search for a broad-spectrum coronavirus treatment, zinc-based drugs were explored.
That is no surprise, given that zinc deficiency is associated with increased susceptibility to infectious diseases caused by bacterial, viral, and fungal pathogens.
The particular type of immune cells that are affected by zinc deficiency are T lymphocytes.
The T stands for thymus gland.
These glandular T-cells are reduced in number by zinc deficiency.
A shortage of zinc also reduces the secretions (thymulin) from the thymus gland.
When viral particles enter the blood circulation they are confronted by so-called naïve T-cells that have not made any antibodies yet. These T-cells aren’t very active without zinc. In fact, the thymus gland itself shrinks from the size of a walnut in adulthood to that of a pea without adequate zinc. Antibody responses are reliant upon zinc.
One report concedes zinc supplementation could improve vaccination success rates.
Instead, toxic adjuvants like mercury and aluminum are inhumanely added to vaccines to provoke an antibody immune response.
But zinc therapy is ignored by modern medicine.
OTHER FACTS YOU SHOULD KNOW ABOUT CORONA VIRUSES
- Including the newly mutated form of the virus, there are a total of seven coronaviruses that can infect humans, the CDC says.
- Corona viruses are not new. They were first identified as RNA viruses in 1970.
- While most of the early reports involving coronavirus were among animals, coronavirus antibodies were reported in humans as early as 1974. So, strains of corona virus didn’t just recently make a jump from animals to humans as widely reported.
Liquorice (licorice) extracts have been used in herbalism and traditional medicine. WARNING: Excessive consumption of liquorice (more than 2 mg/kg/day of pure glycyrrhizinic acid, a liquorice component) may result in adverse effects,such as hypokalemia, increased blood pressure, and muscle weakness.
Also the Main Active Components and Corresponding Targets of Shufeng Jiedu Capsule - a TCM (Traditional Chinese Medicine) against viral infections - contain Licorice:
Names of the 8 plants used for the traditional Chinese medicine (TCM) in Shufeng Jiedu Capsule are identified as: Polygoni Cuspidati Rhizoma Et Radix (Huzhang), Forsythiae Fructus (Lianqiao), Isatidis Radix (Banlangen), Radix Bupleuri (Chaihu), Herba Patriniae (Baijiangcao), Verbenae Herb (Mabiancao), Phragmitis Rhizoma (Lugen), licorice (Gancao), selected the active components and corresponding targets with filter conditions as oral bioavailability (OB) ≥ 30, drug-like (DL) ≥ 0.18.
These article are published for information and awareness. In case you suffer from any medical condition seek the advise of a licensed medical practitioner!
Top 6 Research-Backed Benefits Of Cistus Tea
By Paromita Datta last updated -
Cistus tea or Cistus incanus tea is one of the most ancient teas, brewed for centuries in the Mediterranian regions. It was prized for its medicinal properties and a pleasant aroma. Named the European Plant of the Year in 1999, the cistus tea is making a comeback as people rediscover its many health benefits.
What is Cistus Tea?
Cistus tea is made from the herb Cistus incanus, popularly known as rockrose. It is one of the oldest brewed tea in the world. It was used for medicinal as well as cosmetic purposes. It finds mention in both the Bible and the Quran. The tea is made from the dried flowers and leaves of the plant. It has a pleasant floral taste. One of the best aspects of this tea is its wonderful aroma. In fact, its extract is used as a perfume ingredient.
A cup of cistus tea is full of antioxidants. Photo Credit: Shutterstock
Health Benefits of Cistus Tea
There is good reason cistus tea was considered so beneficial in traditional medicine. It was believed to heal wounds, inflammations, and help regulate one’s health. Modern research has backed up this long-held belief as we find that the plant is indeed rich in antioxidants. So, what you get is a pleasant tasting and fragrant cup of hot tea, full of health benefits.
Cistus was traditionally used for treating Lyme disease. It was believed to prevent and treat the disease. Even today many believe that it can protect people and pets from ticks that are primarily responsible for the disease. Research into the cistus extract used for borreliosis therapy (treatment for Lyme disease) found that it contained a compound named manoyloxides, which made it very effective as a treatment. 
Rich in Antioxidants
The miracle-like medicinal properties of the cistus tea clearly come from its rich deposits of antioxidants. This plant has been researched independently by different scientists and has consistently shown impressive results when it comes to its antioxidant potential. A comprehensive 2018 research on its antioxidant capacity, published in the journal Plants, revealed that it was rich in polyphenols and flavonoids. It was found to be potent in food and for medicinal purposes. 
Reducing Risks of Cardiovascular Disease
Cardiovascular diseases or CVDs are the number one reason for deaths worldwide. The WHO recommends that people who are at high risk need early detection and management. Cistus tea could be useful in that. According to a 2019 study published in Cardiology Journal, Cistus incanus tea decreased CVD risk factors, such as oxidative stress and dyslipidemia (an unhealthy lipid profile). The study recommended a daily intake of Cistus incanus tea for managing CVDs.  
Treating Respiratory Illnesses
One of the common traditional uses of cistus tea was in treating infections. A randomized, placebo-controlled clinical study found that regular consumption of cistus extract significantly reduced the symptoms of common cold among the participants. The researchers credited the presence of polyphenols for this benefit. 
Managing Viral Infections
Viral infections are notoriously difficult to treat, even with potent medications. But natural antidotes like cistus can provide a welcome alternative. A 2016 research published in Scientific Reports found powerful antiviral properties in Cistus incanus extract with low chances of viral resistance. Unlike other natural remedies, it does not harm the host cells. The study, aimed to find herbal alternatives, recommended further research into its potential in managing chronic viral infections. 
Removing Dental Plaque
One of the cistus’ many traditional uses was for oral hygiene. The polyphenols in cistus tea have antibacterial properties that help in removing dental plaque. Research published in the Journal of Dentistry found that rinsing one’s mouth with cistus tea reduces the bacterial adhesion (which causes dental plaque) in the oral cavity. 
How to make cistus tea?
Some people believe that cistus tea must be brewed thrice. But we have a simpler recipe, which is just as effective. The two important factors that you must keep in mind are to ensure that you use filtered water and never let it come to a boil. The tea you will get is as fragrant as it is pleasant.
Cistus Incanus Tea
This medicinal tea has many benefits and has a pleasant floral flavor.
- 3 tsp tea leaves
- 1 ltr filtered water
- honey or stevia optional
Add the tea leaves to the water in a pan and put it on a stove.
Heat the water upto 75 degrees celsius, but not more than 90 degrees celsius. If you do not have a kitchen thermometer, make sure that you do not let the water come to boil.
Bring to a simmer just as you see bubbles start to appear. Cover the pan with a lid to ensure that the volatile compounds present in the leaves do not evaporate. Let the water simmer for 5 minutes.
Let the tea leaves steep for 5 more minutes and then strain. Enjoy your cup of hot tea.
Make sure that you use only filtered water. The presence of other metals and contaminants can interfere with the tea's health benefits.
Where to Buy?
You can get cistus tea at some specialty stores. It is also available online. When buying the tea, make sure that it lists ‘cistus incanus’ as the ingredient. It is also labeled as CYSTUS052. Some brands may use its other popular name, rock rose. Always try to buy organic tea to ensure minimal chances of contamination.
Word of caution: While there is a comprehensive research on the benefits of cistus tea, we do not advise using it as the only treatment for a disease. Talk to your doctor before taking it if you are on any medication. It is also recommended that you talk to a herbalist before taking it for the first time. Lastly, it is not recommended for long-term use or in very large quantities.
Paromita Datta covers the latest health and wellness trends for Organic Facts. An ex-journalist who specialized in health and entertainment news, Paromita was responsible for managing a health supplement for The New Indian Express, a leading national daily in India. She has completed her post-graduation in Business Administration from the University of Rajasthan and her diploma in journalism from YMCA, Delhi. She has completed an e-course, Introduction to Food and Health, from Stanford University, US.
Curing a Virus like Covid19 with Hydrogen Peroxide
By Thomas E. Levy, MD, JD - 21. August 2020
(OMNS August 21, 2020) In an earlier OMNS article, a number of highly effective therapies for COVID-19 were itemized and briefly discussed, along with supporting scientific references for the facts that were presented.  Many of these therapies, alone or in combination with other approaches, have been consistently seen to cure cases of COVID-19, including many cases that were very advanced and even ventilator-dependent.
Yet in spite of all of this information, most physicians, researchers, and the medical literature they generate in abundance continue to ignore this information. And it is now clear that some medical centers and the physicians that represent them will actively suppress the dissemination of this information.
Conscientious physicians who speak out to the contrary face losing their hospital-based employment, and many also face challenges to their licenses from state medical boards. Regardless of where you or your physician stands on the validity of any therapy, the primary fact that dictates whether a therapy is embraced depends almost entirely on how much money can be generated for the doctor, the hospital and the pharmaceutical company.
In addition to the obvious differences between the money generated for natural therapies versus prescription drugs, there are physicians who continually cry out for all clinical therapies to be validated with “large, prospective, double-blind, and placebo-controlled clinical trials.” Truth be known, very few prescription drugs meet this standard.
It is important to note that such trials can only be performed by deep-pocketed drug companies or well-endowed research institutes capable of spending enormous amounts of money (often in the millions of dollars). And neither the research institute nor the drug company has the slightest interest in establishing that expensive drugs can be undercut by any of many effective natural remedies.
Finally, it should be understood that enrolling very sick patients in trials that have a placebo group is highly unethical when the therapy has already been clearly established to have a positive clinical impact with no significant toxicity. These large clinical trials are really only appropriate to establish how effectively a drug relieves disease symptoms along with determining the incidence and degree of toxicity that it can produce.
Stopping the Pandemic: Inhalation Medicine
The only way to stop the COVID-19 pandemic, as well as to prevent or deal with any such future calamities, is to apply a therapy that is highly effective, completely nontoxic, readily available, and inexpensive. Lacking any one of these four aspects of a potential therapy can cripple how well a pandemic can be promptly and readily resolved.
Inhalation Medicine is a growing branch of medicine that is providing a wide array of new approaches to disease via the inhalation of therapeutic agents into the lungs. Although the application of agents via inhalation has been around since ancient times, the current and widely available technology of inexpensive and highly efficient nebulization devices is rapidly expanding this form of medicine application.
Nebulization is a well-established procedure utilized to deliver any of a wide variety of therapeutic agents into the lungs to combat infection and/or improve lung function in different medical conditions. [2-4] Patients with chronic lung disease and asthma are regularly treated with this procedure. The therapeutic agents are dissolved in a solute (often water or saline solution) and converted into a fine mist of such a tiny particle size that it can reach deeply into the lungs. At the same time, such a nebulized agent is also reaching inside the sinuses, along with all the mucosal surfaces in the nasopharynx and oropharynx. Nebulization therapy is being used effectively for the prevention of pneumonia in patients supported on mechanical ventilation.  It is also being increasingly used as an additional option for the delivery of different drugs in patients on mechanical ventilation. 
COVID-19 infections, along with the common cold, influenza, and any other respiratory viral infection, are ideally addressed by nebulizing agents that inactivate viruses and kill cells already having a high virus content. While early intervention with an appropriately prescribed and nebulized pathogen-killing agent can serve as an effective monotherapy, it is best to regard all of the applications of Inhalation Medicine as natural adjuncts to other indicated medical therapies for both respiratory conditions as well as for various chronic diseases. While respiratory infections are most accessible by nebulization, many other conditions in the lungs and the rest of the body can be positively impacted by the nebulization of appropriate agents.
It is important to note that this article seeks only to describe a therapy that is highly effective, potentially accessible to any person on the planet, exceptionally inexpensive, and easily available without requiring a prescription. I am not trying to convince the reader to just nebulize HP and do nothing else. It is vital to your general health as well as to overcome COVID-19 to take all of the quality supplements available and affordable to you, including, but definitely not limited to, vitamin C, magnesium, vitamin D, vitamin K2, iodine, zinc, and quercetin.  That said, however, prompt HP nebulization can be expected to reliably eradicate respiratory and pharyngeal pathogens and to facilitate the rapid recovery from any infection entering the body through the nose or mouth, including COVID-19.
Hydrogen Peroxide (HP) Biochemistry and Physiology
Many people, including physicians, simply regard HP as an effective disinfectant capable of decontaminating surfaces from contaminating pathogens. They recognize its ability to readily clean and disinfect open wounds as well. In fact, HP has been documented to readily kill all pathogens against which it has been tested, including viruses, bacteria, and fungi. Some pathogens require a higher concentration and a longer exposure time to HP in order to be killed, but they all have been documented to succumb. [7-10]
Like all other agents capable of causing oxidation, HP is toxic in high enough concentrations. However, at the low concentration levels to be discussed in this article, it is completely nontoxic. Even the best pharmaceutical drugs can harm and kill. Over 100,000 Americans die annually due to the toxicity of prescription drugs properly dosed and administered for various conditions. Nobody dies from hydrogen peroxide applied at its established, therapeutic concentrations.
A tiny nonionic molecule, HP readily crosses the membranes of both pathogens and cells in the body. HP is literally present everywhere in the body, both inside the cells and in the extracellular spaces.  The normal physiology of the body involves the continual generation of HP throughout the body. Furthermore, HP molecules are actually quite stable and not prone to oxidize surrounding molecules except when certain local conditions exist, as is present in acute and chronic infections.  Pathogens have high levels of reactive (unbound) iron inside them, and it is a process of electron donation from iron to HP inside the pathogen-filled cells or inside the invading pathogens themselves that forms the highly destructive oxidizing agent known as hydroxyl radical. Hydroxyl radicals quickly kill pathogens and also readily destroy cells that are already heavily laden with pathogens.
Because of this ability of HP to generate hydroxyl radical in iron-filled pathogens, it serves as a primary way in which the body mounts a natural defense against infection. In every sense of the word, HP is the body’s natural antibiotic. The generation of HP has been shown to increase in the presence of greater degrees of infection and inflammation.  Activated phagocytes responding to a site of infection and inflammation naturally generate massive amounts of HP into the extracellular space to help deal with the pathogens. [14,15] Very interestingly, phagocytes also have high concentrations of vitamin C, which can help supply the electrons to HP via the free iron present to form hydroxyl radicals. Also, vitamin C is known to help generate increased amounts of extracellular HP for better pathogen-killing. [16.17]
Also, as one might expect from a natural defense mechanism, the by-products of HP that result from its normal metabolism and from its anti-pathogen effects are completely nontoxic, in striking contrast to virtually all prescription agents utilized to treat infections. When HP has been metabolized, only water and oxygen remain. One can actually think of HP as being an effective storage form of oxygen, waiting for the right microenvironment in which to release it. This means that HP can kill pathogens and improve the health of the microenvironment in which the pathogens were killed at the same time.
In a normal, uninfected state, pulmonary epithelial cells, the cells lining the airways of the lungs, naturally excrete and express HP.  This process finely coats HP onto the exposed side of these cells, protecting the lungs from the new pathogens contained in every breath. Of note, when inflammation and infection are already present, increased amounts of HP are found in the exhaled breath.  This is consistent with a natural compensatory mechanism to help contain the infection and keep it from spreading. HP has also been documented to be present in human urine, where it can also provide its anti-pathogen effects.  The ubiquitous and essential role of HP in the body is further reflected in its vital role as a signaling molecule in both the intracellular and extracellular spaces, directly influencing and modulating multiple metabolic processes. 
In addition to its presence throughout the body, both inside and outside the cells, HP is present in drinking water, rain water, and sea water. It is also assimilated from the diet. The relationship of HP to water and oxygen in general is also reflected in the fact that it can be spontaneously generated in microdroplets of water, with tinier droplets resulting in greater degrees of production. [22,23]
HP Nebulization for Respiratory Infections, Including COVID-19
The search for an effective, nontoxic, available, and inexpensive respiratory virus therapy could end with HP. In particular, HP nebulization would be the HP application of choice in this pandemic. Intravenous HP infusions of the correct concentration and administered properly are also highly effective against viruses and other infections, but this application of HP will not satisfy the availability requirement needed to quell a pandemic.
As should now be apparent from the role that HP already plays in the body in protecting against infection, the nebulization of HP into the sinuses, nasal passages, throat, and lungs is just a straightforward and quite elegant way to augment the body’s natural expression of HP to combat infection and inflammation. Individual sensitivities to inhaled HP can vary widely, but a 3% concentration or far lower (even as low as 0.1%) will reliably kill pathogens where they encounter the HP. When the pathogens have been killed, sensitivity to the inhaled HP increases and it is then less well-tolerated, since the mucosal lining cells can be irritated by the HP when it no longer has pathogens upon which to exert its killing/oxidative impact. The only “toxic” effects of inhaled HP consist of minor degrees of nasal and throat irritation that rapidly resolve upon termination of the nebulization. 
Also, while HP is known to kill all pathogens, it is especially effective against viruses encountered via respiratory routes, which is the case with all cold and influenza-causing viruses, including coronaviruses. Large studies examining this clinical impact of HP nebulization remain to be done, but it is already clear that this therapy is effective for many patients, extraordinarily safe, and of inconsequential cost (less than ten cents of HP per nebulization). There is everything to be gained and nothing to be lost in applying HP in this manner. It does not need to displace traditional therapies, as it can augment the positive impact of any other clinical intervention. There are no traditional therapies that nebulized HP works to counteract in any way.
For early onset and treatment of coronavirus:
Regular off-the shelf 3% HP can be utilized. Preparations of greater pharmacological purity can be obtained if desired (food grade). Food grade HP typically comes in concentrations greater than 3% and must be appropriately diluted. HP in a concentration greater than 3% should never be nebulized.
For most adults, the 3% concentration can be utilized in the nebulization chamber undiluted. This optimizes the degree and rapidity of the antiviral and anti-pathogen effect. However, don’t be reluctant to dilute the 3% solution if not easily tolerated. Note that the first few partial inhalations might not be well-tolerated, but these initial inhalations effectively “coat” the mucous membranes with the HP mist, and subsequent inhalations are not only well-tolerated but relaxing. However, never continue inhaling any agent that makes breathing more difficult.
When a runny nose or slightly sore throat is already present, it is recommended that 5- to 15-minute nebulization sessions be undertaken several times daily or until a symptomatic relief is realized. Many individuals report significant improvement only a few hours after the first one or two treatments. However, it would be advisable to persist in these treatments several times daily for at least 24 to 48 hours after you feel everything is completely normal in your sinuses, nose, and throat to assure a complete resolution of the infection.
For some, the 3% concentration results in too much stinging/burning in the nose or soreness in the throat. Such individuals can dilute with water until they find their highest comfortable concentration. Anybody can tolerate a low enough dilution of the HP solution with water. Additional water can always be added until the nebulization is completely comfortable. Lower HP concentrations can be utilized with clearly beneficial effect, but a positive clinical response can be expected to occur more rapidly with the higher concentrations.
As it is a completely nontoxic therapy, HP nebulization can be done as often as desired. If done on a daily basis, a very positive impact on bowel and gut function will also often be realized, as killing the chronic pathogen colonization present in most noses and throats stops the 24/7 swallowing of these pathogens and their associated toxins. When done in the absence of clinical infection, just 1 to 2 minutes of slow, deep breathing with the nebulizer should serve as an excellent preventive measure.
If daily prevention is not a practical option, be ready to nebulize whenever you feel you have had a significant pathogen exposure, as when somebody sneezes in your face or when you finally get off of the plane after a long flight. Don’t wait for initial symptoms. Just nebulize at your first opportunity. Prevention is always easier than remediation.
Of great practical significance, HP nebulizations can also be expected to rapidly resolve a positive COVID-19 test after killing the virus in the nose and nasophyrynx, and quarantine periods can then be shortened, often by many days.
1. Levy T (2020) COVID-19: How can I cure thee? Let me count the ways. OMNS Vol. 16, No. 37. https://orthomolecular.org/resources/omns/v16n37.shtml
2. Shirk M, Donahue K, Shirvani J (2006) Unlabeled uses of nebulized medications. American Journal of Health-System Pharmacy 63:1704-1716. https://pubmed.ncbi.nlm.nih.gov/16960254
3. Martin A, Finlay W (2015) Nebulizers for drug delivery to the lungs. Expert Opinion on Drug Delivery 12:889-900. https://pubmed.ncbi.nlm.nih.gov/25534396
4. Lavorini F, Buttini F, Usmani O (2019) 100 years of drug delivery to the lungs. Handbook of Experimental Pharmacology 260:143-159. https://pubmed.ncbi.nlm.nih.gov/31792683
5. Karimpour H, Hematpour B, Mohammadi S et al. (2020) Effect of nebulized eucalyptus for preventing ventilator-associated pneumonia in patients under mechanical ventilation: a randomized double blind clinical trial. Alternative Therapies in Health and Medicine Feb 21. Online ahead of print. https://pubmed.ncbi.nlm.nih.gov/32088670
6. McCarthy S, Gonzalez H, Higgins B (2020) Future trends in nebulized therapies for pulmonary disease. Journal of Personalized Medicine 10:E37. https://pubmed.ncbi.nlm.nih.gov/32397615
7. Dockrell H, Playfair J (1983) Killing of blood-stage murine malaria parasites by hydrogen peroxide. Infection and Immunity 39:456-459. https://pubmed.ncbi.nlm.nih.gov/6822428
8. Heckert R, Best M, Jordan L et al., (1997) Efficacy of vaporized hydrogen peroxide against exotic animal viruses. Applied and Environmental Microbiology 63:3916-3918. https://pubmed.ncbi.nlm.nih.gov/9327555
9. Berrie E, Andrews L, Yezli S, Otter J (2011) Hydrogen peroxide vapour (HPV) inactivation of adenovirus. Letters in Applied Microbiology 52:555-558. https://pubmed.ncbi.nlm.nih.gov/21418259
10. Goyal S, Chander Y, Yezli S, Otter J (2014) Evaluating the virucidal efficacy of hydrogen peroxide vapour. The Journal of Hospital Infection 86:255-259. https://pubmed.ncbi.nlm.nih.gov/24656442
11. Halliwell B, Clement M, Ramalingam J, Long L (2000) Hydrogen peroxide. Ubiquitous in cell culture and in vivo? IUBMB Life 50:251-257. https://pubmed.ncbi.nlm.nih.gov/11327318
12. Halliwell B, Clement M, Long L (2000) Hydrogen peroxide in the human body. FEBS Letters 486:10-13. https://pubmed.ncbi.nlm.nih.gov/11108833
13. Caffarelli C, Calcinai E, Rinaldi L et al. (2012) Hydrogen peroxide in exhaled breath condensate in asthmatic children during acute exacerbation and after treatment. Respiration 84:291-298. https://pubmed.ncbi.nlm.nih.gov/23018317
14. Root R, Metcalf J, Oshino N, Chance B (1975) H2O2 release from human granulocytes during phagocytosis. I. Documentation, quantitation, and some regulating factors. The Journal of Clinical Investigation 55:945-955. https://pubmed.ncbi.nlm.nih.gov/1123431
15. Root R, Metcalf J (1977) H2O2 release from human granulocytes during phagocytosis. Relationship to superoxide anion formation and cellular catabolism of H2O2: studies with normal and cytochalasin B-treated cells. The Journal of Clinical Investigation 60:1266-1279. https://pubmed.ncbi.nlm.nih.gov/199619
16. Levine M, Padayatty S, Espey M (2011) Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries. Advances in Nutrition 2:78-88. https://pubmed.ncbi.nlm.nih.gov/22332036
17. Pei Z, Wu K, Li Z et al. (2019) Pharmacologic ascorbate as a pro-drug for hydrogen peroxide release to kill mycobacteria. Biomedicine & Pharmacotherapy 109:2119-2127. https://pubmed.ncbi.nlm.nih.gov/30551469
18. Hidvegi M (2020) Inhaled nebulized sodium pyruvate use in COVID-19 patients. The Israel Medical Association Journal 22:278. https://pubmed.ncbi.nlm.nih.gov/32378817
19. Jobsis Q, Raatgeep H, Schellekens S et al. (1998) Hydrogen peroxide in exhaled air of healthy children: reference values. The European Respiratory Journal 12:483-485. https://pubmed.ncbi.nlm.nih.gov/9727806
20. Varma S, Devamanoharan P (1990) Excretion of hydrogen peroxide in human urine. Free Radical Research Communications 8:73-78. https://pubmed.ncbi.nlm.nih.gov/2318421
21. Rice M (2011) H2O2: a dynamic neuromodulator. Neuroscientist 17:389-406. https://pubmed.ncbi.nlm.nih.gov/21666063
22. Lee J, Walker K, Han H (2019) Spontaneous generation of hydrogen peroxide from aqueous microdroplets. Proceedings of the National Academy of Sciences of the United States of America 116:19294-19298. https://pubmed.ncbi.nlm.nih.gov/31451646
23. Zhu C, Francisco J (2020) Production of hydrogen peroxide enabled by microdroplets. Proceedings of the National Academy of Sciences of the United States of America 116:19222-19224. https://pubmed.ncbi.nlm.nih.gov/31484759
24. Ernstgard L, Sjogren B, Johanson G (2012) Acute effects of exposure to vapors of hydrogen peroxide in humans. Toxicology Letters 212:222-227. https://pubmed.ncbi.nlm.nih.gov/22677343
(The views expressed in this article are the author’s and not necessarily that of all members of the Orthomolecular Medicine News Service Editorial Review Board. Readers should consult and work with their own personal physician on any medical matter. OMNS welcomes discussion on a variety of subjects. Readers may submit their own article drafts to the Editor at the contact email below.)
Nutritional Medicine is Orthomolecular Medicine
Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. Read more at orthomolecular.org
How can I cure thee? Let me count the ways.
Commentary by Thomas E. Levy, MD, JD
By Orthomolecular Medicine News Service, July 18, 2020
(OMNS July 18, 2020) Probably never before in history has anything or any event mixed fact, fiction, fear, and confusion like the COVID-19 pandemic of 2019-2020. Political and medical "experts" have been in abundance, primarily regurgitating the same message as though it was something new every time they get interviewed: wash your hands, maintain social distancing, and wear a mask as much as possible. And the public and the news media always take great comfort that an "expert" told them the truth. Trouble is, you can always find another "expert" of equal credentials who will offer a completely contradictory perspective. Understandably, this generates much of the fear and confusion noted above. The good hygiene and virus avoidance advice noted above is helpful, although it is probably a bit overblown when discussing how important a mask is in preventing virus transmission, especially outdoors. It seems ludicrous to mandate mask wearing at all times, indoors and outdoors, although this is being given consideration by some governmental (and medical) authorities at the time of this writing. However, this advice only scratches the surface with regard to the numerous options available to avoid contracting this infection, or to even cure it. There is no point in suffering from misguided advice when COVID-19 can be prevented or reliably cured in short order. As will be clearly explained in this article, nobody needs to die from COVID-19, or even to suffer needlessly (as many virus victims have remained quite ill for months before finally recovering).
While still unknown to most practitioners of traditional, or "modern" medicine, acute viral syndromes, COVID-19 included, can all be easily prevented most of the time. And when such viruses do get a foothold in the body, they are still easily eradicated if the patient is not too close to death before receiving any of a large number of treatments established to be effective. Many doctors get attacked for promoting treatments as cures for afflictions that are traditionally considered to be incurable. Certainly, it is true that some treatments promoted as being reliable cures are either fraudulent or of only nominal benefit. However, failing to assert the validity of a true cure for a medical condition is just as detrimental to the health of an ailing patient as it is promoting a false cure. Many doctors know of highly beneficial treatments that cure or vastly improve medical conditions that are little affected by traditional therapies. Yet, fear of license revocation for telling the truth about inexpensive and natural therapies that cannot be protected by patents keeps most health care practitioners from promoting those beneficial therapies. Nothing is ever embraced, and seemingly not even permitted, that would take away large profits from pharmaceutical companies, hospitals, and even many of the doctors themselves. Whenever you are absolutely stupefied and cannot figure out why a valuable treatment is not being used, just take the time to identify, expose, and analyze the money trail that is involved with the prescription drugs and/or overall treatment protocol that would be displaced.  The reason for the avoidance or suppression of that therapy will then become apparent.
To be perfectly clear: The health of the patient must always be the primary concern whenever rendering medical care.
There exists a first amendment right in the United States that permits free speech, including the writing of books and articles. This right has even protected authors that openly provide information on how to make bombs and promote terrorism. One can only hope that discussing inexpensive and effective medical treatments will continue to receive the same protection. However, it is very clear that this right is rapidly disappearing, in light of the open suppression of free speech that has been occurring for some time, but especially in the last few months. In light of this, then, the information in this article is being presented.
There already exist numerous ways to reliably prevent, mitigate, and even cure COVID-19, including in late-stage patients who are already ventilator-dependent. Some of the modalities have already been proven to work, although not in the classic "prospective double-blind, placebo-controlled trials" conducted on hundreds to thousands of patients. A perceptive clinician realizes that one overwhelmingly impressive case report where an agent or intervention promptly and unequivocally reverses the condition of a rapidly declining patient back to good health simply cannot be dismissed and disparaged as anecdotal and irrelevant. Furthermore, it is the existence of such cases and unequivocally positive responses that makes it completely unethical to put other patients into placebo-controlled trials when the treatment is dramatically beneficial to most patients and harmless to all. Allowing patients in the placebo group to suffer greatly and even die under such circumstances can never be justified.
Unfortunately, even when multiple scientifically-sound clinical studies actually do get conducted and reported on inexpensive, nontoxic, and highly effective therapies, those therapies rarely get utilized clinically. Although there are many examples of such therapies, an especially noteworthy example of the suppression of good medicine is seen with vitamin C. The continued avoidance of the use of intravenous vitamin C, especially in septic patients in the intensive unit,  stands out as a clear example of flagrant malpractice. Conservatively, thousands of ICU patients around the world, on a daily basis, would be saved or at least spared substantial suffering with a simple protocol utilizing intravenous vitamin C. And the morbidity and mortality of many different infections and toxin exposures outside of the ICU setting would also be readily mitigated and even resolved with vitamin C-based protocols. But this is not happening, even though the literature has unequivocally indicated the clinical importance (and safety) of vitamin C for over 80 years. 
The following therapies can be used, and many have been used, to prevent and treat COVID-19 (and many other infections, viral or otherwise). Not all of them have been equally well-documented or proven as being effective. Some have strong literature, research study, and clinical support. Others represent simply logical applications of treatment protocols that have already been proven to be highly effective in eradicating other viral infections and should be expected to have comparable effects on the COVID-19 virus. The treatments described below are categorized as having the ability to prevent, to improve and to cure COVID-19 and other viral syndromes.
Vitamin C (prevents, improves, cures)
Vitamin C has been documented to readily cure all acute viral syndromes in which it has been adequately dosed. As the ultimate virucide, vitamin C has been documented to inactivate/destroy every virus against which it was tested in vitro (in the test tube). Similarly, vitamin C has consistently resolved nearly all acute viral infections in patients treated with sufficient doses. [1,3] Vitamin C has cured Zika fever, another epidemic virus that struck in 2016.  Along with hydrogen peroxide, intravenous vitamin C has also been documented to be highly effective against the debilitating pain of Chikungunya virus.  Intravenous vitamin C has also resolved influenza.  A high degree of protection against infection by many other pathogens is also achievable with a variety of treatments featuring oral forms of vitamin C.
In an ongoing clinical study on hospitalized COVID-19 patients, a combination of vitamin C, methylprednisolone, heparin, and thiamine has already resulted in a dramatic decrease in hospital mortality rate. 
Vitamin D (prevents, improves)
Vitamin D has been clearly documented to strengthen immune function and decrease the risk of infection from any pathogen, including the COVID-19 virus. Patients with the highest vitamin D levels have shorter and less symptomatic courses of infection. While vitamin D has not been demonstrated to cure viruses as a monotherapy, maintaining an adequate level of vitamin D is vital for both preventing the contraction of infectious diseases as well as for recovering more rapidly from such infections, with a clear decrease in mortality rate.  In a recent study not yet published, Indonesian researchers studied the effects of vitamin D on mortality in 780 patients hospitalized with COVID-19. They found that nearly all (98.9%) of COVID-19 patients with vitamin D levels below 20 ng/ml died. Yet, less than 5% with substantially higher levels of vitamin D died. Consistent with these findings, it has been shown that the most life-threatening complication of COVID-19 infection, acute respiratory distress syndrome, occurs much more readily in the presence of a vitamin D deficiency.  Clearly, vitamin D supplementation should be part of any treatment protocol for COVID-19 or any other infectious disease.
Zinc (prevents, improves)
Zinc is needed inside the virus-infected cells to stop virus replication by inhibiting viral RNA polymerase. It is a possibility that many of the younger individuals that are either killed or made severely ill by COVID-19 are chronically zinc-depleted due to inadvertently zinc-deficient diets. Since supplemental zinc has only a limited ability to reach the cytoplasm of cells due to its ionic nature, zinc ionophores (agents that complex with zinc and transport it into the cell) are known to be good general antiviral agents. Quercetin is one such supplement, and it can serve as a good adjunctive agent to any COVID-19 treatment protocol.  Chloroquine, discussed below, is also a zinc ionophore, perhaps explaining its potent anti-COVID-19 effects.
Magnesium Chloride (prevents, improves, may cure)
Magnesium, especially as magnesium chloride, has been documented to have substantial antipathogen properties, and it has been reported to cure poliovirus infections as a monotherapy when ingested orally.  While it remains unclear what an aggressive regimen of this agent would do as a monotherapy for COVID-19, it can be expected to be a positive adjunctive agent in any COVID-19 prevention or treatment protocol.
Ozone (improves, cures)
Ozone is probably the single most potent antipathogen agent available today. It readily eradicates all pathogenic bacteria, fungi, viruses, and protozoa. It has many routes of administration and can be utilized as an effective monotherapy, although it positively supports all treatment protocols in an adjunctive and usually synergistic fashion as well.  Ozone has been documented to cure advanced cases of Ebola virus, for which there are still no known effective mainstream medical therapies.  For someone with ready access to ozone, different applications of ozone could certainly be used to prevent COVID-19 and other respiratory viruses as well. However, with the other simple and effective antiviral measures listed in this article, using ozone for prevention is not really needed.
Hydrogen Peroxide (prevents, improves, cures)
Hydrogen peroxide has been used for many years as a monotherapy as well as part of many different treatment protocols for a wide variety of infections. A clinically effective dose will typically cost less than a dime. During a severe epidemic of influenza in 1919 a protocol of intravenous hydrogen peroxide given only to the most severely ill patients dramatically decreased the death rate. 
Due to its well-documented and potent antipathogen properties, along with producing no toxic byproducts upon killing pathogens, hydrogen peroxide is now being proposed in the literature for an off-label use via oral and nasal washing, a regimen of gargling, and administration via nebulization immediately upon symptom appearance with the presumptive diagnosis of COVID-19. [15,16] Impressive anecdotal evidence already indicates that this application, especially via nebulization, appears to be a powerful preventive and even curative therapy against all respiratory-acquired infections, viral or otherwise.
In addition to nebulization with hydrogen peroxide, a large number of other agents can also be nebulized that have pathogen-killing and mucosal cell-healing properties, including, but not limited to: DMSO, magnesium chloride, sodium ascorbate [vitamin C], nascent iodine, sodium chloride, sodium bicarbonate, zinc chloride, glutathione, and N-acetyl cysteine.
Hyperbaric Oxygen (may improve, may cure)
Hyperbaric oxygen therapy is the breathing of pure oxygen inside a chamber that is pressurized between 1.5 to 3 times normal atmospheric pressure. It has been documented to consistently help eradicate deep-seated and otherwise non-healing wounds and infections.  Ozone therapy, which has destroyed all viruses and pathogens against which it has been tested, has been shown to share some mechanisms of action with hyperbaric oxygen therapy. This certainly raises the reasonable possibility that hyperbaric oxygen might also be a very effective antiviral therapy in addition to its established antibacterial effects. 
Ultraviolet Blood Irradiation (improves, may cure)
Also known as photo-oxidation therapy, ultraviolet blood irradiation therapy has been effectively treating infections for many decades now. In a series of 36 cases of acute polio (spinal type), the blood irradiation treatment was successful in curing 100% of these patients. Viral hepatitis and bacterial sepsis were also found to be very effectively treated with ultraviolet blood irradiation.  This irradiation therapy would likely be equally effective against any other pathogens, especially viruses.
Chlorine Dioxide (improves, cures)
Chlorine dioxide has long been recognized as a powerful antimicrobial agent. It has been around for over 100 years, and it is used both to purify water and to purify blood to be used for transfusion. As a therapeutic agent for infectious diseases, it has been given both orally and intravenously with great effect, and it has been shown to be very effective against COVID-19 as well. [20,21] Dr. Andreas Kalcker directed a clinical study with doctors in Ecuador on COVID-19 patients using oral and intravenous chlorine dioxide. 97% of over 100 COVID-19 patients were vastly improved with clear remission of the severest symptoms after a four-day treatment regimen with chlorine dioxide. No deaths were reported. Oftentimes a dramatic clinical response was seen after only 24 hours.  A clinical study on the effects of oral chlorine dioxide on COVID-19 patients in Colombia was initiated in April of this year. 
Early findings in the Randomized Evaluation of COVid-19 thERapY (RECOVERY) Trial in the United Kingdom indicate that the addition of dexamethasone significantly improved clinical outcome in COVID-19 patients. A 35% reduction in death was seen in treated patients already dependent on mechanical ventilation, and a 20% reduction in death was seen in the treated patient group just receiving supplemental oxygen therapy.  This response of COVID-19 patients on ventilators is very consistent with the benefits of dexamethasone seen with acute respiratory distress syndrome unrelated to COVID-19. 
Budesonide (may prevent, improves, may cure)
Budesonide is a corticosteroid approved for inhalation via a nebulizer (Pulmicort Respules), and it is primarily used for persistent asthma and asthma exacerbations in children and infants as young as 12 months. [26,27] Dr. Richard Bartlett, a West Texas physician, has treated several dozen COVID-19 patients as of mid-June with nebulized budesonide, and he has asserted that all have promptly and dramatically responded positively and none have died. Sequential, or even combined, nebulizations of budesonide and hydrogen peroxide would appear to have great potential for a safe and rapidly effective treatment for any respiratory virus, including COVID-19. The hydrogen peroxide would serve to promptly kill the virus in the airways, and the corticosteroid would relieve the COVID-19 inflammation ("cytokine storm") and the associated shortness of breath. Nebulized budesonide has also been shown to be an effective treatment for preventing fungal infections of the nose and sinuses. 
Patients already on mechanical ventilation can also benefit greatly from the direct nebulization of therapeutic agents through the endotracheal tube. [29,30] This can certainly be done with budesonide  and hydrogen peroxide as well. Too many ventilator-dependent patients are left to eventually overcome the virus with whatever remaining immune capacity they have. Having a treatment that can directly attack the virus present in the lungs while relieving the inflammation with a resultant improvement in oxygenation should result in many of these patients getting weaned off the ventilators and eventually recovering completely. To date, being hospitalized with COVID-19 and eventually ending up on a ventilator still appears to be a death sentence for the vast majority of such patients.
Convalescent Plasma (improves, may cure)
Convalescent plasma is plasma collected from individuals who have recovered from an infectious disease resulting in the formation of antibodies. Depending on the severity of COVID-19 infection and the inherent immune capacity in a given patient, the transfusion of convalescent plasma from recovered COVID-19 patients has nearly always significantly reduced the viral load and clinically improved the patient. When the viral load is lowered dramatically, a clinical cure can be expected. A significantly improved survival rate has been seen in COVID-19 patients who have received convalescent plasma therapy. [32,33]
Chloroquine and Hydroxychloroquine (prevents, improves, cures)
I have had the opportunity to see clear-cut and dramatically positive clinical responses in six individuals with rapidly evolving symptoms consistent with fulminant COVID-19 infection treated with oral chloroquine phosphate. In these individuals (ranging from 35 to 65 years of age), therapy was initiated when breathing was very already very difficult and continuing to worsen. In all six, significant improvement in breathing was seen within about four hours after the first dose, with a complete clinical recovery seen after about an average of three days. The oldest individual had a pulse oximeter reading of 80 before the first dose of chloroquine, and the reading improved to 94 after about four hours as the labored breathing eased. The rapidity with which the shortness of breath evolved in all these individuals strongly suggested that respiratory failure secondary to COVID-19-induced acute respiratory distress syndrome was imminent. The chloroquine dosing was continued for several days after complete clinical resolution to prevent any possible clinical relapse. While a large, definitive study on chloroquine and COVID-19 remains to be completed, there is already a great deal of published evidence supporting its effectiveness and overall safety. [34,35] Also, a recent clinical trial demonstrated that hydroxychloroquine given with azithromycin eradicated or significantly decreased measured viral load in respiratory swabs. 
Both chloroquine and hydroxychloroquine are old drugs that are very safe at the doses shown to be effective in treating COVID-19, and they are both recognized as having significant nonspecific antiviral properties. Also, chloroquine, and probably hydroxychloroquine as well, are zinc ionophores, [37,38] which is likely the reason why they have such significant antiviral properties. As noted above in the discussion on zinc, agents that greatly facilitate zinc transport inside virus-infected cells rapidly accelerate virus destruction and clinical resolution of the viral infection. Many clinicians now feel that chloroquine and hydroxychloroquine therapy for COVID-19 and other viruses is optimized by concomitant zinc administration. [39,40] Certainly, there is no good reason to avoid taking zinc with these agents.
As might be expected, drugs as potently antiviral to COVID-19 as chloroquine and hydroxychloroquine would be expected to be effective preventive agents as well, particularly in the setting where exposure is known or strongly suspected to have taken place, or in a setting where repeated and substantial exposure will reliably occur, as in COVID-19-treating hospitals. [41,42] Many front-line health care workers are on such preventive protocols. But many of the physicians who are taking one of these agents to prevent COVID-19 infection are still resistant to giving it to infected patients. This is difficult to logically reconcile if patient welfare is of the uppermost concern.
Radiotherapy (improves, cures)
In a recent pilot trial at Emory University, five nursing home patients hospitalized with COVID-19 were given a single treatment of low-dose radiotherapy over the lungs. All five patients had radiographic evidence of pneumonia and required supplemental oxygen. All five were felt to be deteriorating from a clinical perspective. The radiotherapy consisted of a 10- to 15-minute application of 1.5 Gy (150 rads). Four of the five patients were noted to have a rapid improvement in their breathing, and clinical recovery was seen to occur between 3 and 96 hours post-irradiation.
While many supplement regimens can be used for COVID-19 prevention, such regimens should include at a minimum vitamin C, vitamin D, magnesium chloride, and zinc. Any of many additional quality nutrient and antioxidant supplements can be added as desired, largely dependent on expense and personal preference.
Nebulizations of powerful antipathogen agents, especially hydrogen peroxide, can readily prevent respiratory viral infections like COVID-19 from taking hold, and initiating such nebulizations even after an infection has been contracted will still make a substantial contribution to a more rapid and complete recovery.
As noted earlier, interventions such as ozone and ultraviolet blood treatments have the potential to be effective monotherapies, although it is always a good idea to accompany such treatments with the baseline supplementation regimen and nebulizations as mentioned above.
In the hospitalized setting, intravenous vitamin C and dexamethasone should always be part of the treatment regimen. Nebulizations with hydrogen peroxide and budesonide can accelerate recovery substantially. Also, patients already on ventilator support should always be given vitamin C and dexamethasone along with these nebulizations in addition to anything else felt to be indicated by the attending physician.
Low doses of hydroxychloroquine or chloroquine along with zinc should always be given in the setting of high-risk exposure. Azithromycin can be taken with these agents as well. Higher doses of these agents should always be part of any regimen in the treatment of a suspected or diagnosed COVID-19 patient, whether asymptomatic or already in the hospital.
While the politics of the COVID-19 pandemic are beyond the scope and aim of this article, there remain no valid medical reasons for not using any of the agents or interventions itemized above for either preventing or treating COVID-19 patients. Furthermore, many combinations of these treatments can be applied, depending on their availability and the clinical status of a given patient. Traditional medicine insists on "proof" of any therapy before it is used routinely, even though this standard of proof is never actually obtained for many of the usual prescription drug approaches to infections and other diseases. When an agent is inexpensive, virtually harmless, and with substantial evidence of providing benefit, there is no justification for a physician to refuse or even actively block its administration to a patient otherwise assured of prolonged suffering and likely death (as with hospitalized COVID-19 patients on ventilation support).
With the treatment options available, there is no good reason for most people to even contract COVID-19, and there is certainly no good reason for anyone to die from this virus, much less have a prolonged clinical course of infection with a great deal of needless suffering.
Please note: None of the information in this article is intended to be utilized by anyone as direct medical advice. Rather, the article is intended only to make the reader aware of other treatment possibilities and documented scientific information that can be further discussed with a chosen health care professional.
(Cardiologist and attorney Thomas E. Levy is the author of a number of books, including Curing the Incurable: Vitamin C, Infectious Diseases, and Toxins; Primal Panacea; and Stop America's #1 Killer. His email is ).
1. Levy T (2011) Primal Panacea, Henderson, NV: MedFox Publishing. ISBN-13: 978-0983772804.
2. Marik P, Khangoora V, Rivera R et al. (2017) Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest 151:1229-1238. https://pubmed.ncbi.nlm.nih.gov/27940189
3. Levy T (2002) Curing the Incurable. Vitamin C, Infectious Diseases, and Toxins, Henderson, NV: MedFox Publishing. ISBN-13: 978-0977952021
4. Gonzalez M, Berdiel M, Miranda-Massari J et al. (2016) High dose intravenous vitamin C treatment for Zika fever. Journal of Orthomolecular Medicine Volume 31. https://www.researchgate.net/publication/309478186_High_Dose_Intravenous_Vitamin_C_Treatment_for_Zika_Fever
5. Marcial-Vega V, Gonzalez-Terron G, Levy T (2015) Intravenous ascorbic acid and hydrogen peroxide in the management of patients with Chikungunya. Bulletin of the Medical Association of Puerto Rico 107:20-24. https://pubmed.ncbi.nlm.nih.gov/26035980
6. Gonzalez M, Berdiel M, Duconge J et al. (2018) High dose intravenous vitamin C and influenza: a case report. Journal of Orthomolecular Medicine Volume 33. https://isom.ca/article/high-dose-vitamin-c-influenza-case-report
7. Frontline COVID-19 Critical Care Alliance (2020) https://covid19criticalcare.com
8. Grant W, Lahore H, McDonnell S et al. (2020) Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients 12:988. https://pubmed.ncbi.nlm.nih.gov/32252338
9. Dancer R, Parekh D, Lax S et al. (2015) Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS). Thorax 70:617-624. https://pubmed.ncbi.nlm.nih.gov/25903964
10. Qiu X, Kroeker A, He S et al. (2016) Prophylactic efficacy of quercetin 3-β-O-D-glucoside against Ebola virus infection. Antimicrobial Agents and Chemotherapy 60:5182-5188. https://pubmed.ncbi.nlm.nih.gov/27297486
11. Levy T (2019) Magnesium, Reversing Disease Henderson, NV: MedFox Publishing. ISBN-13: 978-0998312408.
12. Cepero S, Weiser M (2016) Advances of Ozone Therapy in Medicine and Dentistry. https://www.ozonetherapiesgroup.com
13. Rowen R, Robins H, Carew K et al. (2016) Rapid resolution of hemorrhagic fever (Ebola) in Sierra Leone with ozone therapy. African Journal of Infectious Diseases 10:49-54. https://journals.athmsi.org/index.php/AJID/article/view/3578/2261
14. Oliver T, Murphy D (1920) Influenzal pneumonia: the intravenous injection of hydrogen peroxide. The Lancet Feb 21, pp. 432-433. https://9gurus.com/wp-content/uploads/2020/03/090428.1920.Lancet.H202-Flu.pdf
15. Caruso A, Del Prete A, Lazzarino et al. (2020) Might hydrogen peroxide reduce the hospitalization rate and complications of SARS-CoV-2 infection? Infection Control & Hospital Epidemiology Apr 22, online ahead of print. https://pubmed.ncbi.nlm.nih.gov/32319881
16. Caruso A, Del Prete A, Lazzarino A (2020) Hydrogen peroxide and viral infections: a literature review with research hypothesis definition in relation to the current COVID-19 pandemic. Medical Hypotheses Jun 1, online ahead of print. https://pubmed.ncbi.nlm.nih.gov/32505069
17. Memar M, Yekani M, Alizadeh N, Baghi H (2019) Hyperbaric oxygen therapy: antimicrobial mechanisms and clinical application for infections. Biomedicine & Pharmacotherapy 109:440-447. https://pubmed.ncbi.nlm.nih.gov/30399579
18. Yamanel L, Kaldirim U, Oztas Y et al. (2011) Ozone therapy and hyperbaric oxygen treatment in lung injury in septic rats. International Journal of Medical Sciences 8:48-55. https://pubmed.ncbi.nlm.nih.gov/21234269
19. Rowen R (1996) Ultraviolet blood irradiation therapy (photo-oxidation), the cure that time forgot. Int J Biosocial Med Res 14:115-132. https://drferchoff.com/files/ubiarticle.pdf
20. Zhu Z, Guo Y, Yu P et al. (2019) Chlorine dioxide inhibits the replication of porcine reproductive and respiratory syndrome virus by blocking viral attachment. Infection, Genetics and Evolution 67:78-87. https://pubmed.ncbi.nlm.nih.gov/30395996
21. Kaly-Kullai K, Wittmann M, Noszticzius Z, Rosivall L (2020) Can chlorine dioxide prevent the spreading of coronavirus or other viral infections? Medical hypotheses. Physiology International 107:1-11. https://pubmed.ncbi.nlm.nih.gov/32208977
22. Over 100 Recoverded from Covid-19 with CDS by Physicians of the AEMEMI (2020) https://lbry.tv/@Kalcker:7/100-Recovered-Aememi-1:7
23. Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19 (2020) https://clinicaltrials.gov/ct2/show/NCT04343742
24. Singh A, Majumdar S, Singh R, Misra A (2020) Role of corticosteroid in the management of COVID-19: a systemic review and a clinician's perspective. Diabetes & Metabolic Syndrome 14:971-978. https://pubmed.ncbi.nlm.nih.gov/32610262
25. Villar J, Ferrando C, Martinez D et al. (2020) Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomized controlled trial. The Lancet. Respiratory Medicine 8:267-276. https://pubmed.ncbi.nlm.nih.gov/32043986
26. Szefler S, Eigen H (2002) Budesonide inhalation suspension: a nebulized corticosteroid for persistent asthma. The Journal of Allergy and Clinical Immunology 109:730-742. https://pubmed.ncbi.nlm.nih.gov/11941331
27. Saito M, Kikuchi Y, Lefor A, Hoshina M (2017) High-dose nebulized budesonide is effective for mild asthma exacerbations in children under 3 years of age. European Annals of Allergy and Clinical Immunology 49:22-27. https://pubmed.ncbi.nlm.nih.gov/28120603
28. Dai Q, Duan C, Liu Q, Yu H (2017) Effect of nebulized budesonide on decreasing the recurrence of allergic fungal rhinosinusitis. American Journal of Otolaryngology 38:321-324. https://pubmed.ncbi.nlm.nih.gov/28185668
29. McIntire A, Harris S, Whitten J et al. (2017) Outcomes following the use of nebulized heparin for inhalation injury (HIHI Study). Journal of Burn Care & Research 38:45-52. https://pubmed.ncbi.nlm.nih.gov/27532613
30. Rello J, Rouby J, Sole-Lleonart C et al. (2017) Key considerations on nebulization of antimicrobial agents to mechanically ventilated patients. Clinical Microbiology and Infection 23:640-646. https://pubmed.ncbi.nlm.nih.gov/28347790
31. Turpeinen M, Nikander K (2001) Nebulization of a suspension of budesonide and a solution of terbutaline into a neonatal ventilator circuit. Respiratory Care 46:43-48. https://pubmed.ncbi.nlm.nih.gov/11175237
32. Bloch E, Shoham S, Casadevall A et al. (2020) Deployment of convalescent plasma for the prevention and treatment of COVID-19. Journal of Clinical Investigation 130:2757-2765. https://pubmed.ncbi.nlm.nih.gov/32254064
33. Brown B, McCullough J (2020) Treatment for emerging viruses: convalescent plasma and COVID-19. Transfusion and Apheresis Science 59:102790. https://pubmed.ncbi.nlm.nih.gov/32345485
34. Cortegiani A, Ingoglia G, Ippolito M et al. (2020) A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. Journal of Critical Care 57:279-283. https://pubmed.ncbi.nlm.nih.gov/32173110
35. Devaux C, Rolain J, Colson P, Raoult D (2020) New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? International Journal of Antimicrobial Agents 55:105938. https://pubmed.ncbi.nlm.nih.gov/32171740
36. Gautret P, Lagier J, Parola P et al. (2020) Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents Mar 20, 105949. https://pubmed.ncbi.nlm.nih.gov/32205204
37. Xue J, Moyer A, Peng B et al. (2014) Chloroquine is a zinc ionophore. PLoS One 9:e109180. https://pubmed.ncbi.nlm.nih.gov/25271834
38. Xu Y, Xiao G, Liu L, Lang M (2019) Zinc transporters in Alzheimer's disease. Molecular Brain 12:106. https://pubmed.ncbi.nlm.nih.gov/31818314
39. Derwand R, Scholz M (2020) Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19? Medical Hypotheses May 6, 142:109815. https://pubmed.ncbi.nlm.nih.gov/32408070
40. Shittu M, Afolami O (2020) Improving the efficacy of chloroquine and hydroxychloroquine against SARS-CoV-2 may require zinc additives-a better synergy for future COVID-19 clinical trials. Le Infezioni in Medicina 28:192-197. https://pubmed.ncbi.nlm.nih.gov/32335560
41. Shah S, Das S, Jain A et al. (2020) A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19). International Journal of Rheumatic Diseases 23:613-619. https://pubmed.ncbi.nlm.nih.gov/32281213
42. Huang M, Tang T, Pang P et al. (2020) Treating COVID-19 with chloroquine. Journal of Molecular Cell Biology 12:322-325. https://pubmed.ncbi.nlm.nih.gov/32236562
A Scientific Look at Botanical Plants and Supplements Against Coronavirus
By Richard Gale and Gary Null PhD - Progressive Radio Network - 10. March 2020
In recent weeks, the coronavirus pandemic has dominated the news at the expense of everything else that is critical and urgent in our lives. As panic increases and more cases are reported daily, health-minded people are eager or even desperate to know whether there are ways to strengthen the body’s immune system to offer some protection from this specific upper respiratory infection.
There are six known strains of coronavirus, four which are associated with the common cold or moderate respiratory infections. Everyone has likely had a coronavirus infection at some time in their lives.
However, two strains — Severe Acute Respiratory Syndrome or SARS and Middle East Respiratory Syndrome (MERS) — are more severe. Between the years 2002-2004 and 2014-2018 these strains respectively were observed to be lethal.
However, during these periods, total deaths were under one thousand. SARS has the ability to infect the lower respiratory system as well.
The current strain being called Covid19 is a new mutation that is being recognized as a novel SARS. As of this writing, the current coronvirus has been attributed to over 4,000 deaths, the large majority among the elderly. In a recent press conference the Surgeon General remarked that the average age of death was 80.
Compared to other viral infections that target the respiratory tract, especially influenza, there has been far less research either to understand the pathway of infection and the drugs or natural substances to battle the virus. It remains uncertain how long immunity lasts, if any, after infection.
Seemingly, immunity wanes quickly. Consequently, since coronavirus is most often responsible for a flu-like common cold, recommended prevention and treatment protocols are largely similar to the flu.
Flu Shot Ineffective Against Coronavirus – May Actually Make it Worse
During a recent coronavirus task force meeting, Trump asked whether the flu vaccine would protect against the coronavirus. The flu vaccine is not only influenza-specific, it is also flu strain specific. It offers absolutely no protection to any other viruses.
Nevertheless we are going to likely witness a sharp rise in propaganda recommending flu vaccines to fight the coronavirus scare. The belief is that increasing national flu vaccination compliance will not only reduce the risks of flu infection but will also help divert money away from flu infections to better deal with the rising coronavirus cases.
But there is a caveat. A very serious caveat.
Sometimes the universe has an unusual way of providing warnings that we have an opportunity to either heed or disregard to our benefit or detriment.
On December 31, 2019 in order to usher in the New Year, China reported the first case of an “unusual pneumonia” in its port city of Wuhan. A week later on January 7th, the pathogen was identified as a novel strain of coronavirus.
That same month, the prestigious journal Vaccine, published a study conducted by the Armed Forces Health Surveillance Branch at Wright Patterson Air Force Base. Researchers investigated viral interference due to receiving the flu shot; in other words, does the flu vaccine make a recipient more susceptible to other non-influenza respiratory viral infections? The study’s conclusions state
“Vaccine derived virus interference was significantly associated with coronavirus and human metapneumovirus.”
This is not the first time that viral interference from the flu vaccine has been associated with an increase in non-influenza respiratory infections.
A much more thorough study, an actual clinical trial, was conducted by the University of Hong Kong in 2012. The double blind randomized controlled trial followed a group of flu-vaccinated versus placebo-vaccinated children between 6 and 15 years of age over the course of nine months to determine infection rates from 19 other respiratory viruses. The study found
“no statistically significant difference in the risk of confirmed seasonal influence influenza infection between recipients of the [influenza vaccine] or placebo.”
However, it was the dramatic number of incidences of non-influenza infections found in the flu-vaccinated group (105 cases), which included coronavirus, as opposed to 54 cases among those who received a placebo.
In other words, the results suggest that receiving the flu shot may increase one’s risk of contracting another infectious virus by almost 100 percent.
Coronavirus Infections More Severe Among Older People
A recent analysis out of China reviewing rates of infection, targeted populations and mortality reported that the worst hit group is older people, particularly those who have immune-compromised conditions: cardiovascular disease, hypertension, diabetes, chronic respiratory illnesses, etc.
Taking this statistic into account, we may note that the majority of American adults have some type of chronic condition. It is estimated that 60% of American adults have at least one underlying health condition and 40% have two or more.
For example, 33 million have diabetes and an estimated 84 million are pre-diabetic; heart disease affects 121 million and there are approximately 1.7 million new cancer diagnoses annually. All of these people, therefore, have either a mild to severe compromised immune system.
A Swiss study noted that the SARS coronavirus and influenza share two of the same proteases in targeted cells — TMPRSS2 and HAT. These are responsible for activating the spread of the virus at the point of infection and contribute to their pathogenesis in an infected cell.
Therefore it may be partially conjecture on our part to suggest that natural supplements and botanical remedies that have been shown in the scientific literature to be effective against influenza may more or less be effective against coronavirus as well.
In fact, last month a study was released by Shengjing Hospital of China Medical University in the Journal of Medical Virology recommending that patients’ nutritional status should be evaluated before any conventional treatment. The hospital recommended a regimen that included Vitamins A, B, C, D, E, Omega-3, Selenium, Zinc, gammaglobulin A administered intravenously and Chinese traditional medicine.
Therefore we have scoured the peer-reviewed literature on the National Institutes of Health’s Library of Medicine database to identify compelling studies that may warrant vitamin, antioxidant, and botanical supplementation as a means to protect ourselves from coronavirus and other viral infections.
These have been shown to either have strong antiviral properties in general or have known biomolecular effects to strengthen the immune system against microbial infection. We are not offering prescriptions. This is just a summary of some important scientific information for you to make better informed decisions for protecting yourself while the coronavirus wends its course.
Traditional Chinese Medicine
In Traditional Chinese Medicine (TCM), coronaviral infections belong to a specific epidemic disease category. Astragulus is not only a very popular plant used in TCM, but it is also one of the most researched and promising botanical plants shown to have antiviral properties.
In both TCM and Ayruveda medicinal formulas astrugulus has been prescribed for centuries because of its effectiveness against infections and over-stressed respiratory conditions. Compounds, notably saponins, found in astragulus have been well researched and found to hinder influenza proliferation. The US Department of Agriculture’s Avian Disease and Oncology Laboratory found it inhibits avian flu viruses.
Jinlin Academy of Agricultural Sciences in China conducted a study published in the journal Microbiological Pathology that concluded
“Astragulus exhibits antiviral properties that can treat infectious bronchitis caused by [avian] coronavirus”
In China, which has a large poultry industry, avian coronaviruses are a serious threat to chicken farmers. Chinese farmers will often include astragulus in feed to protect the birds from infection as well as pig feed to ward off porcine circovirus.
Two weeks ago, Beijing University of Chinese Medicine completed an analysis of previous research looking at the benefits of Chinese herbal formulas against the SARS coronavirus and H1N1 flu (swine flu).
In 3 studies, among participants who took formulas against SARS, none contracted the illness. Nor did any contract H1N1 influenza in four additional studies. A primary ingredient in these formulas’ was astragulus.
Earlier in February, researchers at Beijing Children’s Hospital at the Capital Medical University provided a thorough overview of recommended diagnostic procedures and treatments for specific symptoms witnessed in the current Covid19 infections that included both allopathic and traditional Chinese medicine.
In cases where there are signs of severe weakness and stress observed in the lungs and spleen, a formula called Liu Jun Zi is being prescribed, which includes astragulus and ginseng as two primary botanicals.
Last week, the prestigious journal Science published a review out of Yun-nan Academy of Agricultural Sciences in China that investigated the great disparities in infection and mortality rates between different provinces – Wuhan being the most severe.
In the provinces with the lowest infection rates, there was between an 84% to 98% use of TCM formulas. Again, two of the main ingredients were Astragulus and Ginseng.
Licorice Root (Glycyrrhizin Acid)
In traditional medicine licorice root has been used to relieve and treat ulcers, sore throats, bronchitis, coughs, adrenal insufficiencies and allergic diseases. Ancient manuscripts from China, India and Greece all include licorice for treating respiratory tract infections and hepatitis.
Licorice’s main antiviral compounds are known as glycyrrhizins (GL). For 20 years Japan has used glycyrrhizins intravenously to treat chronic hepatitis B and C infections with very rare side effects.
It has also been shown to induce apoptosis in lymphoma cells and Karposi sarcoma related to herpesvirus. Therefore it was an unexpected surprise to discover that there is notable research on glycyrrihizin’s effectiveness against coronavirus and in particular SARS.
Japan’s National Institute of Infectious Disease reported GL’s effectiveness against coronavirus and severe acute respiratory syndrome (SARS) as well as Epstein Barr virus and human cytomegalovirus. After the deadly SARS outbreak in 2012, virologists at Frankfurt University Medical School investigated several antiviral compounds to treat patients admitted with SARS coronavirus infections.
Of all the compounds tested, licorice’s GL was the most effective. The scientists concluded that:
“Our findings suggest that glycyrrhizin should be assessed for treatment of SARS.”
The above research was later replicated at Sun Yat Sen University in China and published in the Chinese journal Bing Du Xue Bao. The researchers identified several derivatives of glycyrrhizin as primary molecules with antiviral properties. In addition to being effective against the SARS coronavirus, they also found it may be effective against herpes, HIV, hepatitis and influenza.
Earlier in 2005, a team of scientists from Goethe University in Germany and the Russian Academy of Sciences had already identified the antiviral activity of GL against SARS coronavirus.
The molecule showed a ten-fold increase in anti-SARS activity compared to other potential treatments tested. One conjugate of GL had a 70-fold increase.
That study was published in the Journal of Medical Chemistry. During that same year, the Chinese Academy of Sciences screened over 200 botanical plants used in Traditional Chinese Medicine to find those with the strong potency SARS coronavirus. Four botanicals stood out. One of the four was licorice’s glycyrrhizin.
Extract of licorice root is the most effective and glycyrrhizin is also available as a separate botanical supplement.
Elderberry (Sambucus nigra)
Elderberry has become a popular supplement for relieving symptoms of the common cold and flu infections. It is found worldwide and is part of many of the world’s indigenous pharmacopias.
There are many species of elderberry; the species Sambucus nigra seemingly has been shown to have the most medicinal qualities. When purchasing Elderberry or Sambucus, it is recommended to note it is Sambucus nigra.
It is better to use a prepared formula rather than try to make it on your own from fresh berries and flowers. Elderberries contain cyangenic glycosides that can be poisonous and cause nausea, vomiting, cramps, diarrhea and weakness.
Most research has focused on elderberry’s therapeutic value against influenza.
Hadassah University Hospital in Israel found that elderberry was effective in vitro against 10 different influenza strains. Cytokine activity for IL-1, TNF-a, IL-6 and IL-8 all significantly increased thereby confirming its anti-inflammatory and antiviral properties.
Another Israeli study by Hebrew University in Jerusalem and published in the Journal of Internal Medical Research found that participants enrolled with existing flu like symptoms who took 15 ml of elderberry syrup 4 times a day recovered four days earlier than those on medications or a placebo.
Finally, a more recent 2019 study by the University of Sydney observed that certain compounds in elderberry inhibit the flu virus’s entry and replication in human cells.
However, there is also research showing elderberry’s positive impact on coronavirus infections.
In 2014, researchers at Emory University noted that elderberry extract inhibited coronavirus virility at the point of infection. The scientists hypothesized that elderberry rendered the virus non infectious.
One of the better studies came out of National Sun Yat Sen University and the China Medical University Hospital in Taiwan in 2019. The researchers used an ethanol extract of Sambucus stem (not the berry) and observed its potential against coronavirus strain NL63.
It is important to remember that deaths being attributed to the coronavirus are more often than not complicated by secondary infections that are usually bacterial such as pneumonia.
In addition to its antiviral properties, elderberry is also effective against pathogenic bacteria. Under laboratory conditions at Justus Liebig University in Germany, elderberry was shown to be very effective against several bacteria that are responsible for pneumonia during flu-like infections, and against Influenza A and B viruses in particular.
A systematic review of the existing research before 2011 by the University of British Columbia and published in the journal Pharmaceuticals, concluded:
“all strains of human and avian influenza viruses tested (including a Tamiflu-resistant strain), as well as herpes simplex virus, respiratory syncytial virus, and rhinoviruses, were very sensitive to a standardized Echinacea purpurea preparation…”
There are different species of Echinacea. The species Echinacea purpurea has been shown to be most effective and targets the most infectious pathogens. When purchasing echinacea, be certain it is the purpurea strain.
Echinicea does present limitations depending upon the severity of an infection. Once a cold caused by any one of the various cold viruses, including coronavirus, more deeply infects the bronchia and the lower lung, echinacea does not appear to be helpful. It is more effective with upper respiratory tract infections.
One of the largest placebo double blind studies on echinacea was conducted by Cardifff University in the UK. The study followed participants for four months and confirmed the safety of long term echinacea supplementation. It also observed a statistically significant decrease in cold episodes in the echinacea group.
There are no strong studies showing echinacea’s effectiveness against coronavirus. Up until 2014, only one study looked at its bioactivities against coronavirus and that was a mouse model which required high doses of the plant extract.
In 2012, Griffith University in Australia undertook one notable double blind study to determine whether echinacea provided protection to air travelers. The study concluded:
“Supplementation with standardized Echinacea tablets, if taken before and during travel, may have preventive effects against the development of respiratory symptoms during travel involving long-haul flights.”
As a piece of consumer advice, a Cornell University study looked at the medicinal properties throughout different parts of the echinicea plant: leaves, stems, bark, roots, etc. The scientists noted that only echinacea extracts that contain the root showed significant antiviral properties. Echinacea appears to modify the clinical course of flu-like respiratory infection by acting upon IL-8, IL-10 and IFN cytokine activity beneficially.
Oleuropein (OLE) is the most important biomolecule in the olive tree that contributes to its antioxidant, anti-inflammatory, anti-atherogenic, anti-cancer, antimicrobial and antiviral activities and effects. One advantage of olive leaf is that it is highly bioavailable to the body’s cells.
There are almost 10,000 studies in the National Institutes of Health literature database referring to OLE, olive leaf, and olive oil, most with respect to its strong antioxidant and anticancer properties. According to analysis conducted by the Regina Elena National Cancer Institute in Rome of the oleuropein content in different parts of the olive plant, extracts made from buds and flowers showed the greatest strength and potency.
Olive leaf has not been shown to be particularly effective against viral upper respiratory infections; however there is considerable evidence to support olive leaf’s ability to strengthen the immune system against infectious viral diseases in addition to possessing many anti-inflammatory qualities.
There are only a few studies showing olive leaf’s effectiveness against respiratory viruses. One randomized trial performed by the University of Auckland in New Zealand suggests olive leaf can contribute to treating respiratory illnesses, including coronavirus. A 2001 study out of the University of Hong Kong identified 6 separate antiviral agents in olive that were effective against parainfluenza and respiratory syncytial virus (RSV).
Olive leaf is also effective against bacterial pathogens. Most bacterial pneumonias are gram-positive. According to a joint study by Arab American University and the University of Central Florida College of Medicine, OLE worked best against gram-positive pathogens but gram-negative organisms appeared to be resistant to OLE (eg, E coli, Salmonellas, etc.).
But OLE does possess notable anti-viral properties. The current Covid19 pandemic appears to utilize the host cell’s ACE2 receptor. This same receptor is also activated in HIV infections. This is one reason why patients infected with this new coronavirus strain are being prescribed HIV drugs. Therefore might olive leaf extract contribute to the treatment for this new coronavirus strain?
New York University biochemists identified olive leaf extract’s anti-HIV activity to modulate the host cell gene expression due to HIV infection. In fact, olive leaf extracts reversed HIV-1 infections. This was published in Journal of Biochemical and Biophysical Research. The conclusions state,
“Treatment with OLE reverses many of these HIV-1 infection-associated changes.”
Another joint study by NYU and Harvard Medical School concluded that OLE from olive leaf is “a unique class of HIV-1 inhibitors” and is “effective against viral fusion and integration.”
Oregano possesses a compound called carvacrol that has been shown to be antiviral. Although it has been tested on several influenza and flu-like respiratory viruses, it does not appear to have been tested against coronavirus.
Soochow University in China and the University of Oklahoma published a study in the BMC Journal of Complementary and Alternative Medicine focusing on oregano’s antiviral properties against influenza viruses. Although oregano did not kill the virus it nevertheless inhibited the virus’ ability to translate proteins responsible for the viral binding to cells.
A University of Putra Malaysia meta-analysis of existing research of different plant essential oils reported oregano was strongest against the flu-like viruses adenovirus and coxsackie virus.
A 2010 randomized double blind study study published in Evidence Based Complementary and Alternative Medicine suggested oregano was beneficial as a throat spray and showed significant and immediate improvement of upper respiratory infectious ailments.
University of Arizona published a paper in the Journal of Applied Microbiologyinvestigating oregano’s antiviral properties when used as a sanitizer. The study focused on one flu-like virus, novovirus. If sprayed on surfaces, carvacrol will kill the virus within 15 minutes of exposure. The most recent research into Covid19’s surface life — living outside of an animal host — is 9 days.
Saikosaponins is an important family of compounds found in the Bupleurum plant, which has been shown to have possible anti-coronavirus properties.
Kaohsiung Medical University in Taiwan examined many of the derivatives of saikosaponins and observed it has very potent anti-coronaviral activity that interferes with the early stage of the virus’ replication. Several companies offer Bupleurum online.
University College Dublin and Sichuan Agricultural University conducted a systematic meta-review of the existing medical literature on Chinese herbs that may prevent and treat viral respiratory infections. Among the most promising herbs against SARS coronavirus were panax ginseng, glycyrrhizin from licorice, and Isatis tinctoria, commonly known as woad or Asp of Jerusalem. Isatis is also available online.
Houttuynia cordata also known as fish mint, rainbow plant, fish wort, bishop’s weed is indigenous to Southeast Asia. This botanical directly inhibits coronavirus’ protease and blocks the viral RNA polymerase activity. A study out of Tsinghua University in Beijing found it significantly reduces fevers, sore throat and coughs due to the SARS virus. Tinctures of this plant are available online.
Unlike the US, most of the world, especially in Asia and continental Europe, recognizes Vitamin C as an important anti-viral agent. It is also a remarkable antioxidant shown to ward off infections. At this moment, China is conducting several clinical trials with intravenous Vitamin C to treat patients infected with the Covid19 strain. The city government of Shanghai is now actively treating patients with intravenous Vitamin C. A trial at Zhongnan Hospital in Wuhan is using 24,000 mg per day intravenously. The Wuhan study can be viewed on the US National Library of Medicine’s website here: https://clinicaltrials.gov/ct2/show/NCT04264533
Until recently, Vitamin C has not been tested against coronavirus. There was one study performed to see whether the vitamin protected chick embryo organs from infection by avian coronavirus — a very common infection in fowl. That study showed the vitamin positively increased embryo resistance against the virus. Otherwise, Vitamin C has only been well studied against other viral infections, especially influenza.
Seoul National University College of Medicine concluded that Vitamin C is an essential factor for anti-viral immune responses at the early stage of Influenza A infection.
In 2017 the University of Helsinki reviewed 148 studies that indicated Vitamin C may alleviate or prevent infections caused by bacteria and viruses. The most extensive indication studied was the common cold. Among people who are physically active, Vitamin C was most beneficial. However, many studies relied on very low Vitamin C doses, which likely contributed to the minor benefits observed. Some of these were as low as 100 mg daily. In addition, the studies showed that colds’ duration was frequently shorter and less severe among people with sufficient Vitamin C levels.
An early randomized double blind trial to investigate Vitamin C’s ability to protect elderly hospitalized patients from acute respiratory infections was conducted at Hudderfield University in the UK. The study relied on a very low dose of 200 mg per day. Nevertheless, those who received the vitamin fared significantly better than those taking placebo.
Finally, there was another controlled placebo study involving 715 students between the ages 18-32 taking 1000 mg four times daily. The test group had an 85% decrease in flu and cold symptoms compared to the control.
Barely a week goes by without another study appearing in the peer-reviewed literature that looks at either Vitamin D’s therapeutic characteristics or the risks of Vitamin D deficiency.
A high number of otherwise healthy adults have been reported to have low levels of vitamin D, mostly at the end of the Winter season. Deficiency rates vary between 42% for the entire population to 82% for Black Americans and 63% for Latinos.
People who are housebound, institutionalized and those who work night shifts are most likely to be vitamin D deficient. This includes many elderly people who receive limited exposure to sunlight.
It has been shown that Vitamin D deficiency is associated with an increase risk in autoimmunity illnesses and greater susceptibility to infection. It also boosts up the body’s mucosal defenses which are critical for protecting ourselves from infectious respiratory viruses
Harvard and Massachusetts General Hospital in conjunction with a global collaborative study to follow up on a Cochrane analysis of 25 randomized controlled trials involving 11,000 participants confirmed that vitamin D. taken daily or weekly significantly cut the risk of respiratory infections in half
Jikei University School of Medicine in Japan conducted a randomized double blind placebo trial to measure the rate that Vitamin D reduced seasonal influenza A. Almost twice as many participants in the placebo group came down with the flu compared to the Vitamin D group. The Japanese scientists also observed that people with a history of asthma were best protected.
For children, a Childrens Hospital of Philadelphia meta review identified 13 of 18 studies confirming that Vitamin D deficiency was associated with increased incidences of acute lower respiratory infection.
Oxidative stress is a well known pathway for microbial infections such as viruses and bacterial pneumonia, especially in the lungs.
When the lungs are subject to serious oxidative stress, there is an increase in inflammatory cytokines, especially IL-1, IL-8 and Tumor necrosis factor or TNF. Each of these cytokines have been shown repeatedly in clinical research to play a role in different respiratory infections including influenza, coronavirus, echovirus, adenovirus, coxsackie virus and others.
Therefore, certain antioxidants can alleviate lung damage due to oxidative stress.
N-acetyl cysteine is one of these extremely important antioxidants. It exhibits both direct and indirect antioxidant properties. The indirect benefit is that it increases the concentration of another important antioxidant, glutathione, in the lung cells.
There is no confirmatory evidence that NAC directly targets flu or flu-like viral infections; however it has been shown to significantly reduce the rate of clinical symptoms.
Johann Goethe University Department of Virology observed that NAC inhibits the replication of seasonal human influenza A viruses by decreasing several these pro-inflammatory molecules. The scientists recommend that NAC should be included as an additional treatment option in the case of an influenza A pandemic.
An Italian randomized placebo study conducted at the University of Genoa found that subjects who were already suspected of having contact with the H1N1 flu virus who were placed under NAC treatment had a 25% rate of experiencing symptoms compared to 79% in the placebo group.
Certain cytokines, especially tumor necrosis factor and IL-6, have been associated with the pathogenesis of influenza and can increase the risk of mortality. In a mouse study, Italian researchers at Zambon Research Center gave NAC to flu-infected mice with a significant decrease in mortality.
Nanoparticle or colloidal silver has been studied extensively for its anti-bacterial properties but less so for infectious viruses. Most studies for silver’s antiviral activities have focused on HIV-1, Hepatitis B, herpesvirus and respiratory syncytial virus or RSV.
In a 2005 issue of the Journal of Nanotechnology, the University of Texas and Mexico University observed that silver nanoparticles could kill HIV-1 within 3 hours, and they suspected that this may be true for many other viruses as well. However, this conclusion may be too premature and more research is necessary.
There are studies showing silver’s efficacy against respiratory viruses. One large study by Japan’s National Defense Medical College Research Institute, published in the Journal of Molecular Sciences, recommended that Japanese healthcare workers take nanosilver to protect them from viruses including coronavirus.
In 2010, the University of Naples measured silver nanoparticles’ capabilities to reduce and prevent infection from the parainfluenza type 3 virus. The scientists hypothesized that the silver may block the virus’ interaction with the cell. Then a joint study by Deakin University in Australia and Osaka University in Japan found that colloidal silver significantly protected cells from H3N2 flu infection and prevented viral growth in the lungs
Finally, colliodal or nanoparticle gold has also been shown to inhibit the flu virus’ binding capaticity to a cell’s plasma membrane. That research was carried out by Freie University in Germany.
Yes, we should be concerned about the coronavirus’ high infectious rate. At the moment, the primary solution being sought to handle the crisis is to spend billions of dollars to develop an effective vaccine and an accurate diagnostic kit.
Additionally, according to a study out of Johns Hopkins University’s School of Public Health, the incubation period is estimated at 5.1 days for being infected and capable of infecting others without displaying symptoms. But there is no mention in the medical community nor the mainstream media about what we can do to strengthen our immune system.
Yes, a high quality 99% barrier mask is important, especially if worn in a crowded environment.
Repeated washing of our hands for a full minute with soap water. Rub surfaces with alcohol at home and work and allow it to sit for 30 seconds. Likewise, wipe down door handles and telephone receivers.
Quarantining people who have been exposed is important until they test negative.
Closing schools is prudent. And if a vaccine is eventually developed and shown to be safe and effective that is another recourse.
However none of the above protects the immune system in the event of coming into contact with the virus. We believe that the recommended natural solutions shared above, since they are supported in the peer reviewed scientific literature, are something everyone can do. Besides, it is safe and not expensive.
Therefore these natural solutions too should be considered as a viable and effective recourse to lessen this pandemic’s fatal effects.
Favilavir, the first approved coronavirus drug in China
The National Medical Products Administration of China has approved the use of Favilavir, an anti-viral drug, as a treatment for coronavirus. The drug has reportedly shown efficacy in treating the disease with minimal side effects in a clinical trial involving 70 patients. The clinical trial is being conducted in Shenzhen, Guangdong province.
It is the first anti-novel coronavirus drug that has been approved for marketing by the National Medical Products Administration since the outbreak. Developed by Zhejiang Hisun Pharmaceutical Company, the drug is expected to play an important role in preventing and treating the epidemic, the government said on its official WeChat account.
Three potential anti-COVID19 medicines have been officially announced by the Ministry of Science and Technology: Favilavir, HydoxyChloroquine, and Remdesivir. They all initially showed more obvious curative effects and lower adverse reactions in clinical trials.
However the drug Remdesivir completely failed to help in cases of Ebola, for which it was originally developed.
Full peer reviewed study has been released by Didier Raoult MD, PhD https://t.co/DzFTv13wYn.
After 6 days 100% of patients treated with HCQ + Azithromycin were virologically cured
— Gregory Rigano (@RiganoESQ) March 18, 2020
(... but consult and discuss with your physician, because Chloroquine can have serious side-effects in patients.)
The other one with the most potential – so far – has been Remdesivir, which Gilead had already been developing as a treatment for Ebola disease and Marbug virus infections. It has subsequently also been found to show antiviral activity against other single-stranded RNA viruses such as respiratory syncytial virus, Junin virus, Lassa fever virus, Nipah virus, Hendra virus, and coronaviruses (including MERS and SARS viruses).
WARNING! In the case of glucose-6-phosphate dehydrogenase (G6PD) deficiency, called favism, which is genetically prevalent in about 30% of all black Africans, as well as in many African-Americans, but also especially among the Khazarian Jews among the Kurds (50% of men), Jews and to a much lower percentage in southern Europeans or Europeans, and is genetically determined, it is certain that with administering higher doses of anti-malarial medicines such as Quinine - analogous chloroquine (Resochin BAYER), primaquine as well as hydroxychloroquine - death can occur within a short time due to hemolysis, i.e. the destruction of red blood cells, partially along with acute renal failure. READ ON
How to treat Coronavirus infection COVID-19
Interview with the member of the Russian Academy of Science Alexander Chuchalin
Translated by Scott Humor - 14. March 2020
If a situation with the CAVID-19 coronavirus infection follows the same scenario as the SARS epidemic, then by April- May the problem will be less acute. In his interview to the RT the academic Alexander Chuchalin, the Head of Department of Hospital therapy of the Russian National Research Medical Pirogov University. In his opinion, the Russian healthcare system has done its best to protect the country from coronavirus. The doctor also says that, contrary to popular belief, infection with CAVID-19 can be accompanied by a runny nose.
Q: Not only are you one of the best pulmonologists in Europe, you are also in the main risk group now for coronavirus. Could you, please, give some recommendations for people of your generation and those who are younger, those who, as we see, are really susceptible to high mortality — especially in China, Italy, and Iran.
A: In order to understand the risk groups for this disease: first of all, these are people who come into contact with animals that represent a biological reservoir. For example, in 2002 it was African cats, in 2012 it was camels, and now the science is a little confused, it has not been fully established. There is more evidence that this is a certain kind of bat — the one that the Chinese eat.
This bat spreads the coronavirus through its bowel movements. After that a seeding process takes place. Let’s say, it’s a seafood market or some other products, and so on. But, right now we’re talking about an epidemic, we are talking about people infecting people. Therefore, this phase has already arrived. The infection spreads person to person.
Coronaviruses are a very, very common viral infections, and people encounter them many, many times in their lives. Within a year a child carries diseases that we call acute colds up to ten times. And behind this acute cold are certain viruses.
And the second place in its prevalence is occupied by the coronavirus. The problem is that these seemingly harmless pathogens were dismissed, and they could never understand the cause-and-effect relationship between a common cold and a virus. If, say, a child has a cold, he has a runny nose, what will follow? And so on. For about two weeks, a child or an adult gets sick — and all this disappears without a trace.
But in 2002, 2012, and now in 2020, the situation has changed qualitatively. Because the serotypes that have started to circulate … they affect the epithelial cells.
Epithelial cells are cells that line the respiratory tract, gastrointestinal tract, and urinary system. Therefore, a person infected has pulmonary symptoms and intestinal symptoms. And in the study of urine tests, too, allocate… with such a viral load.
But these new strains, which we are now talking about, they have these properties — to come into contact with the second type of receptor, the angiotensin-converting enzyme. And this receptor is associated with such a serious manifestation as cough.
Therefore, a patient who has symptoms of damage to the lower respiratory tract, a characteristic sign is a cough. This affects the epithelial cells of the most distal parts of the respiratory tract. These breathing tubes are very small.
Q: Distal, is it distant?
A: It’s far and small in diameter.
Q: So this is what we have next to the bronchi?
A: This is bronchi, then we have bronchioles, respiratory bronchioles. And when the air, the diffusion of gases goes on the surface of the alveoli, they pass just this section of the respiratory tract.
Q: That is, the primary symptom is a cough…
A: No, the first is a runny nose, and a sore throat.
Q: They say that there is no runny nose.
A: No, these are big data issues. 74 thousand medical records were processed, and all of them have rhinorrhea (runny nose. – RT). When you are told this — there are really some nuances. Biology is like this. The biological target of the virus is epithelial cells. The nose, oropharyngeal region, trachea, and then small bronchioles, targeting these regions are especially dangerous to humans. And it turned out that, having this mechanism, the virus leads to a sharp breakdown of the immune system.
A: An explanation that science gives today is that a protein called interferoninduced protein-10 is involved in the process. It is with this protein that the regulation of innate immunity and acquired immunity is associated. How should we see this? As a very deep damage to lymphocytes.
Q: So you can see lymphocytes falling immediately on the general test?
A: Yes. And if there are white blood cells increase, platelets will increase, and it is more stable lymphopenia, that is, the lymphotoxic effect of the viruses themselves. Therefore, the disease itself has at least four outlined stages. The first stage is virusemia. A harmless cold, nothing special. Seven days, nine-approximately in this interval.
But starting from the ninth day to the 14th, the situation changes qualitatively, because it is during this period that viral and bacterial pneumonia is formed. After damage to epithelial cells in the anatomical space of the respiratory tract, colonization of microorganisms occurs, primarily those that inhabit the human oropharyngeal region.
Q: Do you mean bacteria that is already there?
A: Bacteria, Yes. Therefore, these pneumonias are always viral and bacterial.
Q: So the virus, so to speak, fills the alveoli, where some bacteria live all the time? And they live somewhere by themselves, in some quantity?
A: In general, we believe that the lower respiratory tract is sterile. This is how the defense mechanism works for the lower respiratory tract.
Q: There’s nothing there?
A: It’s not inhabited. When the virus has entered and it has broken this barrier, where there was a sterile environment in the lungs, microorganisms begin to colonize and multiply.
Q: So it’s not a virus that causes pneumonia? Still, pneumonia is caused by bacteria, of course.
A: It’s the association of virus-bacteria.
This is the window where the doctor must show his skill. Because often the virusemic period is like a mild disease, like a slight cold, malaise, runny nose, a slight temperature is small, subfebrile. But the period when the cough increased and when there is a shortness of breath — these are two signs that say: stop, this is a qualitatively different patient.
If this situation is not controlled and the disease progresses, then more serious complications occur. We call it respiratory distress syndrome, shock. A person cannot breathe on their own.
Q: Pulmonary edema?
A: You see, there are a lot of different edemas of a lung. In fact, it depends on how it happens. To be precise, we call this non-cardiogenic pulmonary edema. If, say, cardiogenic pulmonary edema can be treated with certain medications, then this pulmonary edema can only be treated with a mechanical ventilation machine or advanced methods such as extracorporeal hemoxygenation.
If a person transfers to this phase, the immunosuppression caused by the defeat of the acquired and innate immunity becomes fatal and the patient is joined by such aggressive pathogens as Pseudomonas aeruginosa, fungi. And the cases of death that occurred — 50% of those who were on artificial ventilation for a long time, the alveoli are all filled with fungi.
Fungi appear during the stage of deep immunosuppression. What is the fate of the man who endured all this? That is, he suffered virusemic period, he suffered viral-bacterial pneumonia, he suffered respiratory distress syndrome, non-cardiogenic pulmonary edema, and he suffered septic pneumonia. Will he be healthy or not? And, in fact, today the world is concerned about this: what is the fate of those 90 thousand Chinese who have suffered a coronavirus infection?
Q: But those 90 thousand — they recovered by themselves, they weren’t kept on on a ventilator, they did not get fungi. ARI or acute respiratory infection, that’s it?
A: But the problem itself is very important. Because practical medicine is faced with the fact of a sharp increase in the so-called pulmonary fibrosis. And this group of people who have had a corona virus infection develops fibrosis of the lung within a year.
Q: That is, when the lung tissue thickens?
A: Yes. A lung becomes like burnt rubber, if the analogy is to be made.
Q: Say, you get an elderly person who has been accurately diagnosed with a coronavirus. And he is not yet on the ninth day, that is, he does not need to be put on a ventilator yet. How will you treat him?
A: You know what the problem is: we do not treat such patients yet, because there are no medications, medicines that should be used in this phase. There is no panacea. Because a drug that would act on virusemia, on the viral-bacterial phase, on non-cardiogenic pulmonary edema, on sepsis — is a panacea, this drug doesn’t exist.
Because if we go back to the experience of 2002, when we saw the vulnerability of medical personnel, doctors and nurses were recommended to use Tamiflu and oseltamivir — an anti-influenza drug. And with certain serotypes of the coronavirus, indeed, the mechanism of introduction into the cell is the same as with influenza viruses. Therefore, it has been shown that these drugs can protect individuals who are at high risk of developing this disease.
Or, he is identified as a carrier of the virus, he is given these drugs and so on. But this, I want to say again, has no serious evidence base. The situation that is most threatening, because it determines the fate of a person. A cold is one thing. And another thing a viral-bacterial pneumonia, it is a fundamentally different thing.
And here it is very important to emphasize that it is problematic to help such a patient only with antibiotics. There must be a combination therapy, which includes means that stimulate the immune system. This is a very important point.
Q: What do you mean? So, relatively speaking, you will prescribe him Amoxiclav with some kind of immunomodulator?
A: Yes, we would usually prescribe fourth-generation cephalosporins, not Amoxiclav, in combination with vancomycin. This combination is broad, because very quickly there is a process of a change of gram-positive and gram-negative flora. But what immunomodulatory drug to prescribe is a question for scientific research.
So, we understand that the immune system will suffer dramatically. We understand the high vulnerability of a person to the infection that begins to colonize the respiratory tract. So, unfortunately, we don’t have a clear line. But what really can help such patients in this situation is immunoglobulins. Because this is substitution therapy.
And therefore, such patients are prescribed high immunoglobulins so that they do not develop sepsis, at least they do not enter the sepsis phase. American doctors used this drug in their Ebola patient. This is a group drug, an analog of nucleosides. This is a group of drugs that are used for herpes, cytomegalovirus, and so on.
Q: So this is antiviral or antiviral-supporting therapy, right?
A: No, this is a drug that still acts on the mechanisms in the cell that resist virus replication. Here in my hands (photo of US President Donald trump. – RT). He gathered all the top people who could speak out on promising drugs. Two questions that he raised, he was preparing for this conference. The first question is: how ready are scientists in the United States of America to introduce the vaccine?
Q: Eighteen months.
A: Yes, absolutely. That’s two years. He asked what in this case? Does the country have drugs that could protect? And, as a matter of fact, they said: Yes, there is such a drug.
A:What kind of drug is this? It’s called Remdesivir
Q: Let’s look at it.
A: That’s what scientists said, given the experience that we have, and discussions and so on. Although, of course, there are other drugs that are being actively studied. In general, this direction is very interesting: in fact, it is considered promising. The use of mesenchymal stem cells is considered promising. But at what stage?
Q: As a person who has been doing this for many years, treating everything from asthma to pneumonia, can you somehow try to predict the development of this epidemic, for example, in Russia?
A: I want to say that if we compare Russia with the surrounding world in case of the coronavirus of 2002. We didn’t have a single patient here.
Q: Maybe we just didn’t diagnose them?
A: As you know, there are strong aspects of Russian healthcare in this situation, and I would like to stress this. This is the work of our sanitary and epidemiologic services. They really did their best to protect our country. This is on one side, as if punitive measures. And on the second side is the work of the Vector Research Institute, which made diagnostics for the coronavirus in a very short time, and they did everything absolutely. And it was tested at the CDC, and they got a certificate indicating high specificity and sensitivity.
Q: The Vector diagnostic kit is the only certified
Q: The virus is already in Russia, no matter how much the sanitary service tries. How do you think it will develop? Will it end in the spring, for example, with the arrival of summer?
A: You know, I think the picture repeats what it was then with the SARS. If you remember…
Q: Then? Do you mean in 2002? When it was SARS?
A: Yes, that’s the one. If we follow this scenario, we should say that somewhere in April or May this problem will become less acute.
Q: Just because of the seasonal cessation of respiratory infections?
A: Yeah. The climate factor and a number of other factors. Now, the trouble, of course, comes to us not from China, but from Europe. Those who return from these countries, primarily from Italy, today, remember: Carlo Urbani. He accomplished a lot of things. I think this is just a hero of a doctor who has done so much. He was a virologist from Milan.
Q: Back in 2002?
A: He was a WHO expert. I met with him through the World Health Organization. He was on the list as an expert on coronaviruses. And then he was sent to Hanoi. They were dispatching doctors, and he got to go to Vietnam. And in Vietnam, when he arrived, there was a panic. Their doctors stopped coming to work. Their medical staff, also. There had patients, but there wasn’t any medical personnel and no doctors.
He assessed the situation. With difficulty, he managed to break it, to remove this panic situation that was then in the hospital. But most importantly, he began to communicate with the government and said: close the country to quarantine. That’s where it all came from. It came from Urbani. They started to fight back.
Q: The Vietnamese?
A: Yes, the government of Vietnam. That this would affect the economy, tourism, and so on. But, he found these words, he convinced them. And Vietnam was the first country to come out of this. And he thought his work was done. He collected material for a virological examination and boarded a plane to Bangkok.
He was supposed to meet with the American virologists there. During the flight, he realized that he got ill. He got sick, just like those poor Vietnamese in that hospital. And he began to write everything down and describing it. This is this exact time, and this is how I feel.
Q: The flight was about three hours?
A: Yes, about three hours. And during these three hours, he became an invalid who couldn’t get up and move on his own. Here we see how the window itself works, and we understand when pneumonia joins — this window can be extremely, extremely short in duration. And when he was barely able to get down the aircraft ladder, he left the last entry: “I’m waving to them so they don’t come near me.”
That is, American virologists wanted to meet Urbani, but he said: let’s not contact. He died in an intensive care unit. And there was an autopsy. And from his lung tissue was isolated a strain that was named after him – “Urban I-2”. Here is a very story that I am telling you. A tragedy, of course.
Q: What would you recommend to a person who finds himself… Well, we have already agreed that the virus is in the general population. We can’t really control it anymore.
A: Are you asking for some simple recommendations? First of all, take a good care for the nasal mucosa and oropharyngeal area.
Q: To wash it with saltwater?
A: Yes, wash it thoroughly. But “lors” – non-prescription medications and sinus cleaners to stop running nose and for an effective lavage. That is, the feeling of free unobstructed breath should come after all. The second thing is the oropharyngeal area behind the uvula. And there, too, you need to make a good lavage of the oropharyngeal region.
Q: So you don’t just have to squirt it up your nose, you have to gargle it deep down your throat?
A: Yes, and rinse it out. And don’t be lazy. Do do it until you get a feeling of clean, good airways. Of all the ways, this is the most effective. I would advise those people who can afford to buy a nebulizer or…
Q: Do you mean, it’s aerosol, right? With ultrasound?
A: Yes. And it allows the hygiene of the upper respiratory tract to be brought to a good state. When a cough starts, it is desirable to still apply the medications that we prescribe for patients with bronchial asthma. This is either Berodual, or Ventolin, or Salbutamol. Because these drugs improve mucociliary clearance, relieve spasm.
Q: You mean expectorant?” Mucolytic ACC?
A: Yes, ACC and Fluimucil. And what you can’t do is use glucocorticosteroids. This virus replication is rapidly increasing by them.
Q: What does that mean?
A: Corticosteroids is prednisone, methylprednisolone, dexamethasone, betamethasone.
Q: So you don’t need to inject hormones, relatively speaking, if you have a viral infection?
A: There are inhaled steroids. But there are patients with asthma who are ill and are on this therapy. But this has to be a tailor-made solutions. Of course, 2020 will go down in medical history as a year of a new disease. We must admit that we have understood this new disease. Two new pneumonias have arrived. First is pneumonia, which is caused by e-cigarettes, vapes, and now in the United States, people have died from this…
Q: …several thousand teenagers. Yes, this is a well-known fact, and how to treat it is unclear. You put them on a ventilator — they die immediately.
A: Yes. Do you understand what the problem is? Here they develop those changes in the lungs that occur during this process. They seem to be similar (to the changes from the coronavirus). This is respiratory distress syndrome, which we are talking about. The literature raises very serious questions: the role of coronaviruses in transplantation. One of the problems is obliterating bronchiolitis, which occurs especially during transplantation.
Q: A lung transplant?
A: Yes, lungs and bone marrow. Stem cell. As a matter of fact, everything is well done, everything is normal, the person has responded to this therapy, and the problem of respiratory failure is beginning to grow. And the cause of these bronchiolitis was caught — it is a coronavirus… That is, new knowledge has come.
How to treat Coronavirus infection COVID-19 in Russian
TOP ADVISE: IVERMECTIN
By VF - 15. February 2020
Discuss with your doctor the use of Ivermectin, which has shown a dramatic and life-saving impact on patients affected by the so-called novel corona virus.
If your doctor advises against Ivermectin, then find another doctor, because yours obviously hasn't studied the evidence proving that it helps effectively and safely (using not more than about 20 mg per kg bodyweight) per day.
Nobody needs to die from the bioweapon.
We used it safely since many years against parasites in humans and animals, but found it to cure a wide range of sicknesses and ailments.
Try to find Ivermectin ad usum humanum (for humans), but if you do not get it, then you can use the widely available veterinary form produced by a good pharmacuticl company to help in an acute emergency.
Police cordon off a residential estate in Hong Kong. The global death toll from coronavirus could be massive, says Gabriel Leung. Photograph: Anthony Wallace/AFP via Getty Images
The coronavirus epidemic could spread to about two-thirds of the world’s population if it cannot be controlled, according to Hong Kong’s leading public health epidemiologist.
His warning came after the head of the World Health Organization (WHO) said recent cases of coronavirus patients who had never visited China could be the “tip of the iceberg”.
Prof Gabriel Leung, the chair of public health medicine at Hong Kong University, said the overriding question was to figure out the size and shape of the iceberg. Most experts thought that each person infected would go on to transmit the virus to about 2.5 other people. That gave an “attack rate” of 60-80%.
“Sixty per cent of the world’s population is an awfully big number,” Leung told the Guardian in London, en route to an expert meeting at the WHO in Geneva on Tuesday.
He will tell the WHO meeting that the main issue is the scale of the growing worldwide epidemic and the second priority is to find out whether the drastic measures taken by China to prevent the spread have worked – because if so, other countries should think about adopting them.Even if the general fatality rate is as low as 1%, which Leung thinks is possible once milder cases are taken into account, the death toll would be massive.
The Geneva meeting brings together more than 400 researchers and national authorities, including some participating by video conference from mainland China and Taiwan. “With 99% of cases in China, this remains very much an emergency for that country, but one that holds a very grave threat for the rest of the world,” the WHO director-general Tedros Adhanom Ghebreyesus said in his opening remarks. To date China has reported 42,708 confirmed cases, including 1,017 deaths, Tedros said.
People in Yokohama, Japan, look at the cruise ship Diamond Princess, where dozens of passengers tested positive for coronavirus. Photograph: Issei Kato/Reuters
Leung – one of the world’s experts on coronavirus epidemics, who played a major role in the Sars outbreak in 2002-03 – works closely with other leading scientists such as counterparts at Imperial College London and Oxford University.
At the end of January, he warned in a paper in the Lancet that outbreaks were likely to be “growing exponentially” in cities in China, lagging just one to two weeks behind Wuhan. Elsewhere, “independent self-sustaining outbreaks in major cities globally could become inevitable” because of the substantial movement of people who were infected but had not yet developed symptoms, and the absence of public health measures to stop the spread.
Epidemiologists and modellers were trying to figure out what was likely to happen, said Leung. “Is 60-80% of the world’s population going to get infected? Maybe not. Maybe this will come in waves. Maybe the virus is going to attenuate its lethality because it certainly doesn’t help it if it kills everybody in its path, because it will get killed as well,” he said.
Experts also need to know whether the restrictions in the centre of Wuhan and other cities have reduced infections. “Have these massive public health interventions, social distancing, and mobility restrictions worked in China?” he asked. “If so, how can we roll them out, or is it not possible?”
There would be difficulties. “Let’s assume that they have worked. But how long can you close schools for? How long can you lock down an entire city for? How long can you keep people away from shopping malls? And if you remove those [restrictions], then is it all going to come right back and rage again? So those are very real questions,” he said.
If China’s lockdown has not worked, there is another unpalatable truth to face: that the coronavirus might not be possible to contain. Then the world will have to switch tracks: instead of trying to contain the virus, it will have to work to mitigate its effects.
Disinfectant sprayed on people entering a residential compound in Tianjin, China. Photograph: STRINGER/Reuters
For now, containment measures are essential. Leung said the period of time when people were infected but showed no symptoms remained a huge problem. Quarantine was necessary, but to ensure people were not still carrying the virus when they left, everybody should ideally be tested every couple of days. If anyone within a quarantine camp or on a stricken cruise ship tested positive, the clock should be reset to 14 days more for all the others.
Some countries at risk because of the movement of people to and from China have taken precautions. On a visit to Thailand three weeks ago, Leung talked to the health minister and advised the setting up of quarantine camps, which the government has done. But other countries with links to China appear, inexplicably, to have no cases – such as Indonesia. “Where are they?” he asked.
Scientists still do not know for sure whether transmission is through droplets from coughs or possibly airborne particles. “It’s rather difficult to do that kind of careful detailed work when everything is raging. And unless it is raging you are unlikely to get enough confirmed cases,” he said. “In Sars we never had the chance to do these kinds of studies.”
Hong Kong, which has 36 confirmed cases of coronavirus, was in the worst possible set of circumstances for fighting a raging epidemic, said Leung.
“You need extra trust, extra sense of solidarity, extra sense of goodwill, all of which have been completely used up – every last drop in that social capital fuel tank has been exhausted after now eight months of social unrest, so it couldn’t have come at a worse time,” he said.
Health workers in protective gears evacuate residents from a public housing building in Hong Kong. Photograph: Tyrone Siu/Reuters
Orgasm boosts your immune system, helping you fight off infection and illness
Can an orgasm a day really keep the doctor away?
By Jaimee Bell - 04. February 2020
Orgasms help minimize pain and promote relaxation which can help boost our immune system. Photo by Marko Aliaksandr on Shutterstock
- Also achieving orgasm through masturbation provides a rush of feel-good hormones (such as dopamine, serotonin and oxytocin) and can re-balance our levels of cortisol (a stress-inducing hormone). This helps our immune system function at a higher level.
- The surge in "feel-good" hormones also promotes a more relaxed and calm state of being, making it easier to achieve restful sleep, which is a critical part in maintaining a high-functioning immune system.
- Just as bad habits can slow your immune system, positive habits (such as a healthy sleep schedule and active sex life) can help boost your immune system which can prevent you from becoming sick.
How an orgasm affects your brain...
Orgasms are a very common human phenomenon. The physical and mental health benefits have been researched frequently as a result, and yet, there is still so much to be learned about how our bodies and brains react to the chemicals and hormones released during and after experiencing this type of sexual release.
"The amount of speculation versus actual data on both the function and value of orgasm is remarkable" explains Julia Heiman, director of the Kinsey Institute for Research in Sex, Gender, and Reproduction.
Masturbation causes a rush of dopamine, which is a chemical that is associated with our ability to feel pleasure. Along with the rush of dopamine that is released during an orgasm, there is also a release of a hormone called oxytocin, which is commonly referred to as the "love hormone."
This concoction of chemicals does more than just boost our mood, it also can play a key role in decreasing stress and promoting relaxation. Oxytocin decreases cortisol, which is a stress hormone that is usually present (in high volumes) during times of anxiety, fear, panic, or distress.
According to BDSM and fetish researcher Dr. Gloria Brame, an orgasm is the biggest non-drug induced blast of dopamine that we can experience.
By boosting the oxytocin and dopamine levels and subsequently decreasing our cortisol levels, the brain is placed in a more relaxed, euphoric, and calm state.
Sex boosts your immune system and raises your white blood cell count.
Sexual arousal and orgasm increase the number of white blood cells in the body, making it easier to fight infection and illness. Image by Yurchanka Siarhei on Shutterstock
How do those effects on the brain from reaching orgasm translate to boosting our immune system and making our body healthier?
The increase of oxytocin and dopamine that causes a decrease in cortisol levels can help boost our immune system because cortisol (well-known for being a stress-inducing hormone) actually helps maintain your immune system if released in small doses.
According to Dr. Jennifer Landa, a hormone-therapy specialist, masturbation can produce the right kind of environment for a strengthened immune system to thrive.
A study conducted by the Department of Medical Psychology at the University Clinic of Essen (in Germany) showed similar results. A group of 11 volunteers were asked to participate in a study that would look at the effects of orgasm through masturbation on the white blood cell count and immune system.
During this experiment, the white blood cell count of each participant was analyzed through measures that were taken 5 minutes before and 45 minutes after reaching a self-induced orgasm.
The results confirmed that sexual arousal and orgasm increased the number of white blood cells, particularly the natural killer cells that help fight off infections.
The findings confirm that our immune system is positively affected by sexual arousal and self-induced orgasm and promote even more research into the positive impacts of sexual arousal and orgasm.
Sexual arousal and orgasm can ease and prevent pain, which allows you to achieve the restful sleep that helps your immune system stay strong and healthy.
The benefits of masturbation have long been debated, but the more research that is done on the topic the more we understand that there are many positive reactions that happen in our bodies and brains when we orgasm.
Orgasms can help prevent or mitigate pain, which boosts the immune system, preventing cold and flu symptoms.
According to neurologist and headache specialist Stefan Evers, about one in three patients experience relief from migraine attacks by experiencing sexual activity or orgasm. Evers and his team conducted an experiment with 800 migraine patients and 200 patients who suffered from cluster-headaches to see how their experiences with sexual activity impacted their pain levels.
The study showed that 60% of migraine sufferers experienced pain relief after participating in sexual activity that resulted in orgasm. Of the cluster-headache sufferers, about 50% said their headaches actually worsened after sexual arousal and orgasm.
Evers suggested in his findings that the people who did not experience pain relief from migraines of headaches during their sexual activity did not release as large amounts of endorphins as those who did experience pain relief.
According to rheumatologist Dr. Harris McIlwain, people who suffer from chronic pain have immune systems that are simply not functioning at full capacity - therefore, alleviating pain (through orgasm, as an example) can help boost the immune system.
Orgasms can also promote relaxation and make it easier to fall asleep. Serotonin, oxytocin, and norepinephrine are all hormones that are released during sexual arousal and orgasm, and all three are known for counteracting stress hormones and promoting relaxation, which makes it much easier for you to fall asleep.
There are several studies showing that serotonin and norepinephrine help our body cycle through REM and deep non-REM sleeping cycles. During these sleep cycles, the immune system releases proteins called cytokines, which target infection and inflammation. This is a critical part of our immune response. Cytokines are both produced and released throughout our bodies while we sleep, which proves the importance of a good sleep schedule to a healthy immune system.
Sex promotes a high-functioning immune system; a healthy immune system prevents cold and flu.
The immune system is a balanced network of cells and organs that work together to defend you against infections and diseases by stopped threats like bacteria and viruses from entering your system. While there are many things we need to do to keep our immune systems functioning at optimal levels, masturbation (or other means of achieving orgasm) has proven to have positive effects on the immune system as a whole.
Just as bad habits (such as an inconsistent sleep schedule or harmful chemicals in your body) can slow your immune system, positive habits (such as a healthy sleep schedule and active sex life) can help boost your immune system.
New disease is greater threat than ebola and could overwhelm NHS
Fourth UK patient falls ill as country faces ‘major’ coronavirus outbreak, warns world expert
A fourth patient in England has been diagnosed with coronavirus as a microbiologist warned that the country could suffer a “major outbreak” which is likely to become a pandemic.
The new patient contracted the infectious disease in France after coming into contact with a previously confirmed UK case and is being treated at the Royal Free Hospital in London.
A British man in Majorca has also tested positive for the virus, the local government said. His wife and two daughters have not contracted it, but health officials are working to track down other individuals the man may have had contact with.
Medics work at an isolation unit in Wuhan, epicentre of the outbreak - Picture: YUAN ZHENG
Professor Chris Whitty, the chief medical officer for England, confirmed the new UK case hours after another repatriation flight brought more than 200 people ... The Times has a paywall
.... but don't forget to stay away from 5G
WUHAN, Oct. 31 2019 (Xinhua) -- The branches of Chinese major telecom operators in central China's Hubei Province announced Thursday the launch of commercial 5G applications in the province.
Wuhan City, the capital of Hubei, is expected to have 10,000 5G base stations by the end of 2019, said Song Qizhu, head of Hubei Provincial Communication Administration.
China Telecom has established a 5G network covering airports, railway stations and other areas in the city, which will also help boost the digital and intelligent transformation of the industries with 5G technologies, said Li Hongbo, general manager of the company's Hubei branch.
China Mobile Hubei Branch has activated 1,580 5G base stations in the city as of mid-October, achieving the 5G coverage of universities, transportation hubs and other densely populated areas, according to the branch.
WUHAN, Feb. 2020 (Xinhua) -- China's first trial 5G wireless network on a college campus has been established in the Huazhong University of Science and Technology (HUST), China Mobile said Wednesday. The network will enable applications of technologies such as online distant learning featuring augmented reality and virtual reality and campus patrolling with night-vision drones, said an official with HUST, which is located in central China's Hubei Province. The network was developed by a laboratory jointly set up by HUST, China Mobile's Hubei branch and tech company Ericsson in June last year. So far, China Mobile has installed 100 5G base stations in Wuhan, the capital of Hubei, and is launching large-scale tests, according to Fan Bingheng, general manager of the company's Hubei branch. Test data showed that the 5G network is able to provide a peak single-user download speed of 1.6 Gbps, nearly 16 times faster than that of 4G service.
Exposure to 5G waves leads to .... " flu-like symptoms."